Over 500 References Supporting EDTA Chelation - Jace Medical ...
Over 500 References Supporting EDTA Chelation - Jace Medical ...
Over 500 References Supporting EDTA Chelation - Jace Medical ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Over</strong> <strong>500</strong> <strong>References</strong> <strong>Supporting</strong> <strong>EDTA</strong> <strong>Chelation</strong><br />
1. Toyota H, Shibata S (Kyoto University). Supplementary studies on pharmacology of disodium<br />
ethylenediaminetetraacetate (<strong>EDTA</strong> salt). Nippon Yakuriguku Zasshi. 1956;52:1-9. (CA51:11567e)<br />
2. Uhl HSM, Brown HH, Zlatkis A, Zak, B, Myers GB, Boyle AJ. Effect of ethylenediamine-tetraacetic<br />
acid (EDT) on cholesterol metabolism in man. Preliminary report of effect of parenteral and oral<br />
administration of disodium and calcium salts. Am J Clin Pathol. 1953; 23:1226-1233. (CA48:2257d)<br />
3. Vasil'eva OG. (Inst Ind Hyg Occup Dis, Acad Med Sci, USSR) Side effects of CaNa2 ethylenediaminetetraacetate<br />
in experimental lead intoxication. Gigiena 1 Sanitariya. 1961;26:22-5 (Mar.). (979)<br />
4. Vozar L. Complexons in food products and their effect on the metabolic processes. Prumysl potravin.<br />
1958; 9:649-653. (CA53:8461i)<br />
5. Vozar L. Effect of complexon III on the distribution of calcium and phosphorus in bones. Biologia.<br />
1958; 13:695-699. (CA55:5762e)<br />
6. Williams JD, Leigh DA. (Edgware General Hospital) Lead poisoning. Letters to the editor. British Med J.<br />
1964; 1:1511 (June 6). (2841)<br />
7. Williams JD, Matthews GA, Judd AW. (St. Paul's Hospital) Oral calcium disodium versenate in<br />
treatment of lead poisoning. British J Ind Med. 1962; 19-211-215 (July). (2491)<br />
8. Windsor E, Cronheim GE (Riker Labs, Inc.). Gastrointestinal absorption of heparin and synthetic<br />
heparinoids. Nature. 1961; 190:203-204. (CA55:23818a) [Heparin Na U.S.P. and the K salt of<br />
sulfopolyglucin can be absorbed from the gastrointestinal tract when given orally with an alk. salt of<br />
ethylenediaminetetraacetic acid (I). The chelation of Ca and (or) Mg ions by I may be involved.]<br />
9. Windsor E (to Riker Laboratories). Orally active therapeutic compositions, especially polysaccharide<br />
sulfates. U.S. 3,088,868 (Cl 167-55). May 7, 1963, Appl Aug. 18, 1958. (CA59:12598d)<br />
10. Wynn JE, Van't Riet B, Borzelleca JF (Med. Coll. of Virginia). Toxicity and pharmaco-dynamics of<br />
EGTA: oral administration to rats and comparisons with <strong>EDTA</strong>. Toxicol Appl Pharmacol. 1970; 16(3):807-<br />
817. (CA73)<br />
11. Yang SS. Toxicological investigations of ethylenediaminetetraacetic acid. Dissertation. Univ. Mass.<br />
1952:94 p.<br />
12. Rieders F, Copeland JE (Jefferson Med Coll). Inhibition of accumulation of chronically ingested lead in<br />
rats by simultaneous feeding of edathamil calcium disodium (Na2Ca<strong>EDTA</strong>). Federation Proceedings. 1956;<br />
15:Abstract No. 1541 (Mar.). (693)<br />
13. Schuttmann C, Schuttmann W (Inst. Of Occup Med, Berlin-Lichtenberg). The medical prevention of<br />
occupational lead poisoning by oral administration of calciumdinatrium ethylenediaminetetraacetate.<br />
Zeitschrift fur Arztliche Fortbildung. 1963; 57:1301-1307 (Dec.). (2621)<br />
14. Shiels DO, Thomas DLG, Kearley E. Treatment of lead poisoning by edathamil calcium-disodium.<br />
AMA Arch of Ind Health. 1956; 13:489-498 (May). (1718)<br />
15. Savicevic M, Petrovic L. Prevention of industrial lead poisoning. Vojnosanitetski Pregled. 1962;<br />
19:531-535 (July-Aug.). (3191)
16. Salvini M (Univ. Padua). The calcium chelate of disodium ethylenediamine tetraacetate in the treatment<br />
of saturnism. Folia Medica (Naples). 1955; 38:2:111-126. (1616)<br />
17. Saruta N, Yamaguchi S. A new diagnostic method of occupational lead poisoning for group inspection.<br />
J Sci of Labour (Japan). 1957; 33:540 (July). (1855)<br />
18. Ritter J, Dacquet J (Inst. Hyg. Rabat, Morocco). Detection and ambulatory treatment of lead poisoning<br />
by oral administration of calcium di-sodium versenate. Maroc <strong>Medical</strong>. 1961; 40:377-382 (Apr.). (2323)<br />
19. Remy R (Inst. Physiol. Vet. Coll.). Experimental studies on lead poisoning in animals. I. Toxicology. II.<br />
Therapy and prophylaxis. Deutsche Tierurztliche Wochenschrift. 1956; 63:385-388; 405-408 (Oct. 1; 15).<br />
(692)<br />
20. Pott R. Control of lead exposure as practiced in a lead foundry. Zentralplatt fur Arbeltsmedizin<br />
Arbeitsschutz. 1961; 11:211-214 (Sept.). (2317)<br />
21. Pott R. Is prophylaxis of lead poisoning with <strong>EDTA</strong> possible? Archiv fur Gewerbe-pathologie<br />
Gewerbehygiene. 1959; 17:4:354-364. (2053)<br />
22. Pettinati L, Gribaudo C, Rasetti L. Oral and intravenous versenate in the therapy of chronic lesions<br />
caused by lead. Minerva Medica. 1962; 53:2092-2097 (July). (2458)<br />
23. Pendergrass JC. The effects of the chronic ingestion of low levels of inorganic mercury(11) and<br />
mercury(11) complexed with <strong>EDTA</strong> on the rodent neuronal cytoskeleton: possible role of these forms of<br />
environmental mercury exposure in the etiology of Alzheimer's disease. Diss Abstr Int B (Avail. Univ.<br />
Microfilms Int., Order No. DA9527428. 1975; 1995:56(4). (CA)<br />
24. Oser BL, Oser M, Spencer HC. Safety evaluation studies of calcium <strong>EDTA</strong>. Toxicol Appl Pharmacol.<br />
1963; 5:142-162. (CA59: 9223a)<br />
25. Moeschlin S. The clinical picture and therapy of lead poisoning. Zeitschrift fur Unfallmedizin<br />
Berufskrankheiten 51. 1958; 2:129-149. (1936)<br />
26. Myslak Z, Buczkowski M. The effect of calcium versenate (Ca-<strong>EDTA</strong>) on the kidney in the treatment<br />
of lead poisoning. Polskie Archiwum Medycyny Wewnetrznej. 1961; 31:853-856. (2304) [Kidney function<br />
tests (creatinine clearance, RN) were carried out on 20 out of 120 cases of chronic Pb poisoning treated by<br />
oral administration of Ca<strong>EDTA</strong>. The results showed no harmful effect of <strong>EDTA</strong> on the kidneys during<br />
treatment.]<br />
27. Myslak Z. Treatment of chronic saturnism by oral administration of calcium versenate. Medycyna<br />
Pracy. 1960; 11:353-368. (2169)<br />
28. Nakaue HS, Thomas JM, Reid BL. Comparison of <strong>EDTA</strong>, terephthalic acid, sodium sulfate and acetylsalicylic<br />
acid as antibiotic potentiating agents in broiler chicks. Poultry Sci. 1967; 46:417-421. (NA38)<br />
29. Vozar L. Relation between peroral application of complexon 3 (ethylenediaminetetraacetic acid<br />
disodium salt) and the activity of alkaline phosphatase of blood serum. Biologia. 1960; 15:208-211. Z Inn<br />
Med. 1959; 14:676. (CA54:25290h)<br />
30. Thomsen MK, Jacobsen C, Skibsted L II. Mechanism of initiation of oxidation in mayonnaise enriched<br />
with fish oil as studied by electron spin resonance spectroscopy. Eur Food Res Technol. 2000; 211(6):381-<br />
386. (CA)
31. Sidbury JB Jr., Bynum JC, Fetz LL. (US Public Health Serv.) Effect of chelating agent on urinary lead<br />
excretion. Comparison of oral and intravenous administration. Proceedings of Soc Experimental Biol and<br />
Med. 1953; 82:226-228. (1444)<br />
32. McMahon FG. Comparison of the effect of Fe 3-specific (N, N-dihydroxyethylglycine), versenol, and<br />
calcium disodium versenate on urinary iron excretion in a patient with hemochromatosis. J Lab Clin Med.<br />
1956; 48:589-602. (CA51:3027c)<br />
33. McPhail AP, Patel RC, Bothwell TH, Lamparelli RD. <strong>EDTA</strong> and the absorption of iron from food.<br />
Amer J Clin Nutr. 1994; 59(3):644-648. (NA64)<br />
34. Manville IA, Moser R. Recent developments in the care of workers exposed to lead. The effect of the<br />
calcium chelate of disodium ethylenediamine-tetraacetic acid on led in the blood and urine of battery<br />
workers. AMA Arch Ind Health. 1955; 12:528-538 (Nov.). (1587)<br />
35. Heimbach J, Rieth S, Mohamedshah F, Slesinski R, Samuel-Fernando P, Sheehan T, Dickmann R,<br />
Borzelleca J. Safety assessment of iron <strong>EDTA</strong> (sodium iron (Fe3+) ethylenediaminetetraacetic acid):<br />
summary of toxicological, fortification and exposure data. Food Chem Toxicol. 2000; 38(1):99-111. (CA)<br />
[A review with many refs. Iron <strong>EDTA</strong><br />
36. Davidsson L, Kastenmayer P, Hurrell RF. Sodium iron <strong>EDTA</strong> (NaFe(III)<strong>EDTA</strong>) as a food fortification:<br />
the effect on the absorption and retention of zinc and calcium in women. Amer J Clin Nutr. 1994;<br />
60(2):231-237. (NA64)<br />
37. Foreman H, Trujillo TT. Metabolism of carbon14-labeled ethylenediaminetetraacetic acid in human<br />
beings. J Lab Clin Med. 1954; 43:566-571. (CA48: 8949a)<br />
38. Foreman H. The pharmacology of some useful chelating agents. Metal Binding Med, Proc Symposium,<br />
Philadephia 1959. 1960; 82:94. (CA54:17719e)<br />
39. Bradley JE, Powell AM Jr. Oral calcium <strong>EDTA</strong> in lead intoxication of children. J Ped. 1954; 45:297-<br />
301 (Sept.). (2882)<br />
40. Capellaro F, Galdo PC, Alliod R. Possibility of treating saturnism by versenate by the oral route.<br />
Minerva Medica. 1963; 54:474-477. (2508)<br />
41. Calabrese A, Astolfi E, Mariani F. Oral treatment of lead intoxication with calcium versenate. Clinical<br />
and experimental study. Dia Medico. 1961; 33:2292-2294 (Oct. 5). (2239)<br />
42. Cotter LH. Treatment of lead poisoning by chelation. JAMA. 1954; 155:906-908. (CA52:10388a)<br />
43. Choie DD, Copley MP, Gindhart TD. Mitigation of intestinal cytotoxicity of cisplatin by <strong>EDTA</strong> in rats.<br />
Cancer Lett. 1983; 19(2):195-198. (CA)<br />
44. Cohn SH. The effect of chemical agents on the skeletal content and excretion of internally deposited<br />
fission products. US Atomic Energy Comm. ANL-5584. 1956; 144-149. (CA51:4557f)<br />
45. Flanagan PR, Chamberlain MJ, Valberg LS. The relationship between iron and lead absorption in<br />
humans. Am J Clin Nutr. 1982; 36(5):823-9. (CA)<br />
46. Forbes RM. Excretory patterns and bone deposition of zinc, calcium, and magnesium in the rat as<br />
influenced by zinc deficiency, <strong>EDTA</strong>, and lactose. J Nutr. 1961; 74:194-200. (CA59:7921b)
47. Davidson L, Almgren A, Hurrell RF. Sodium iron <strong>EDTA</strong> (NaFe(III) <strong>EDTA</strong>) as a food fortificant does<br />
not influence absorption and urinary excretion of manganese in healthy adults. J Nutr. 1998; 128(7): 1139-<br />
1143. (CA)<br />
48. Desoille H, Albahary C, Truhaut R, Boudene C. The lead mobilization test using CaNa2<strong>EDTA</strong>. XII<br />
Intern Cong Occup Health. Helsinki, Finland. 1957; Vol. 111, Proceedings, pp. 287-290. (1773)<br />
49. Davies NM, Jamali F. Pharmacological protection of NSAID-induced intestinal permeability in the rat:<br />
effect of tempo and metronidazole as potential free radical scavengers. Hum Exp Toxicol. 1997; 16(7):345-<br />
349. (CA)<br />
50. Kalz F, Quastel J II, Telner P, Schafer A, MacIntyre W. Changes in the electrophoretic patterns of the<br />
serums of psoriatics under various forms of therapy. J Invest Dermatol. 1958; 31:161-166. (CA53:20529a)<br />
51. Kehoe RA. Misuse of edathamil calcium-disodium for prophylaxis of lead poisoning. J Amer Med<br />
Assoc. 1955; 157:341-342 (Jan. 22). (1582)<br />
52. Mariani B, Bisetti A, Romeo V. Blood-cholesterol-lowering action of the sodium salt of<br />
calciumethylenediaminetetraacetic acid. Gazs Intern Med Chir. 1957; 62:1812-1823. (CA51:16953c) [Two<br />
g. daily of the drug, in 2 intravenous administrations, or (with a lower effect) by mouth or rectum, caused in<br />
humans a decrease of blood cholesterol, especially of its free fraction.]<br />
53. Stankovic M, Petrovic LJ, Poleti D (Inst. Public Health, Belgrade, Serbia). A contribution to the<br />
laboratory diagnostics of early saturnism. Arhiv za Higijenu Rada 1 Toksikologiju. 1962; 13:189-194.<br />
(2480)<br />
54. Srbova J, Telsinger J (Clinic Occup. Dis., Prague). Absorption of calcium disodium salt of<br />
ethylenediaminetetraacetic acid after oral administration in the treatment of lead poisoning. Archiv fur<br />
Gewerbepatholgie und Gewerbehygiene 15. 1957; 6:572-580. (1858)<br />
55. Suenaka T, Kosaka H, Miyama K, Tabuchi T, Hirata M, Hara I, Masumoto D, Akaboshi S (Osaka<br />
Prefect Inst. Public Health, Osaka). The effects of repeated oral administration of calcium-<strong>EDTA</strong> on<br />
patients with chronic lead poisoning. Osaka-furitsu Koshu Eisei Kenkyusho Kenkyu Hokoku, Rodo Eisei<br />
Hen. 1979; 17:1-9. (CA)<br />
56. Suenaka T, Miyajima K, Kosaka H, Tbuchi T, Hara I. Urinary excretion of heavy metals following oral<br />
administration of calcium <strong>EDTA</strong>. Osaka furitsu Koshu Eisei Kenkyusho Kenkyu Hokoku, Rodo Eisei Hen.<br />
1976; 14:19-23. (CA)<br />
57. Swenerton H, Hurley L S (Dept. Nutr. Univ. Calif., Davis, Calif.). Teratogenic effects of a chelating<br />
agent and their prevention by zinc. Science. 1971; 173 (3991), 62-64 (Eng). (CA75)<br />
58. Telsinger J, Srbova J. Effect of D-penicillinamine on the urinary excretion of mercury and lead.<br />
Pracovni Lekarstvi 16. 1964; 10:433-435. (2827) [Seven patients with chronic Pb poisoning were treated<br />
with daily oral doses of 150 mg D-penicillinamine for 4-7 days. Urinary excretion of Pb increased about 4fold<br />
which is practically as much as after administration of 0.5-g tablets of Ca<strong>EDTA</strong>, 4 times/day. If future<br />
studies confirm its lower toxicity in long-term administration, D-penicillinamine may replace <strong>EDTA</strong>.]<br />
59. Tripod J. General pharmacodynamic aspects of mobilizing iron with chelators. Atti Acad Med<br />
Lombarda, Suppl 20. 1965; 2025-2027. (CA67)<br />
60. Tufft LS, Nockels CF. The effects of stress, escherichia coli, dietary ethylenediamine-tetraacetic acid,<br />
and their interaction of tissue trace elements in chicks. Poult. Sci. 1991; 70(12):2439-2449. (CA)
61. Tolot F, Jaquis GM, Soubrier R, Bresson JR. Lead mobilization in, and the &-aminolevulinic acid<br />
(ALA) content of the urine of lead-exposed subjects. Egesesegiudomany. 1966; 10(4):375-380. (CA66)<br />
62. Tolot F, Jaquis GM, Soubrier R, Bresson JR. The use of chelating agents "per os" in the treatment of<br />
prophylaxis of lead poisoning. Proceedings of the Society of Ind Med at Lyon. 1962; 23:376-379 (June).<br />
(2484)<br />
63. Perrault M. Truhaut R, Klotz B, Boudene C, Dreux C, Clavel B, Chain F. The effectiveness of<br />
Ca<strong>EDTA</strong>, in occupational lead poisoning. Archiv des Maladies Professionelles de Medecine du Travail et<br />
de Securite Sociale. 1956; 17:423-429; discussion 470-472. (1702)<br />
64. Mitchell Jr PH, Schroeder HA. Depression of cholesterol levels in human plasma following<br />
ethylenediamine tetracetate and hydralazine. J Chron Dis. 1955; 2:520-533. (CA54:18787i)<br />
65. Prasad T, Chhabra A, Atreja PP. Effect of feeding chelating agent (<strong>EDTA</strong>) on trace mineral balances in<br />
goats. Indian J Dairy Sci. 1994; 47(3):219-221. (CA)<br />
66. Rodriguez A. Substances that potentiate the absorption of vitamin B12 administered orally. Anales Inst.<br />
Farmacol. Espan. 1961; 9-10, 57-61. (CA61:2373a)<br />
67. Rotta C, Parigi A. Prevention of lead intoxication by oral administration of calcium versenate. Med del<br />
Lavoro. 1961; 52:769-779 (Dec.). (2325)<br />
68. Saita G, Moreo L. Lead and porphyrins in the bile of patients with lead poisoning treated with calcium<br />
versenate. Med del Lavoro. 1958; 49:376-384 (May). (1956)<br />
69. Scadding G, Bjarnason I, Brostoff J, Levi AJ, Peters TJ. Intestinal permeability to 51CR-labelled<br />
ethylenediaminetetraacetate in food-intolerant subjects. Digestion. 1989; 42(2):104-109. (NA59)<br />
70. Sidbury Jr JB. Lead poisoning, treatment with disodium calcium ethylenediamine-tetraacetate. Am J<br />
Med. 1955; 18:932-946 (June). (1622)<br />
71. Bersworth Chemical Co. The versenes for exacting chemical control of cations in solution. Technical<br />
Bulletin No. 2, 4th ed. 1952; 102 pp. (1313)<br />
72. Berti T. Pharmacological investigation on sodium bismuth ethylenediaminetetraacetate (Bi-<strong>EDTA</strong>).<br />
Arch Ital. Sci. Farmacol. 1956; 6:293-298. (CA51:9939h)<br />
73. British Industrial Biological Research Association. The metabolism of <strong>EDTA</strong>. Food and Cosmetics<br />
Toxicol. 1964; 2:741-745 (Dec.). (2670)<br />
74. Gervais MJ. The medical prevention of lead poisoning in an electrolytic zinc factory. Montpellier<br />
<strong>Medical</strong>. 1962; 61:12-27 (Jan.). (2401)<br />
75. Jugo S, Maljkovic T, Kostial K. Influence of chelating agents on the gastrointestinal absorption of lead.<br />
Toxicol. Appl. Pharmacol. 1975; 34(2):259-263. (CA)<br />
76. Teisinger J, Zumanova R, Zezula I. Effect of calcium salt of ethylenediaminetetraacetic acid on the<br />
binding of lead by erythrocytes and blood proteins. Pracovni lekufstvi. 1957; 9:277-280. (CA52:9447g)<br />
77. Stancev S. Prophylaxis of chronic lead poisoning by oral administration of CaNa2<strong>EDTA</strong>. First National<br />
Congress of Industrial Health. Abstracts of papers. 1963; 37-38. (2634)
78. Taucin EJ, Svilane ABV. Effect of <strong>EDTA</strong> and chlortetracycline on assimilation of trace elements by<br />
chickens. Fiziologiceski aktivnye komponenty pitanija zivotnyh. 1969; 163-170 Russian. (NA41)<br />
79. Suenaka T, Miyajima K, Kosaka H, Tabuchi T, Hara I. Urinary excretion of heavy metals following<br />
oral administration of calcium-<strong>EDTA</strong>. Osaka-furitsu Koshu Eisei Kenkyusho Kenkyu Hokoku, Rodo Eisei<br />
Hen. 1977; 15:27-31. (CA) [Ca <strong>EDTA</strong>, administered to workers dealing with Pb, significantly increased Pb<br />
and Zn excretion in urine. There was a high correlation between urinary total metal and Zn concns.]<br />
80. Nishino S. Effect of oral administration of calcium ethylenediaminetetraacetate in lead poisoning.<br />
Kokumin Eisel. 1957; 26:90-95. (1834)<br />
81. Nottbohm L. The supervisory physician in plants presenting lead hazards. Medizinische Welt. 1963;<br />
44:224-228. (2596)<br />
82. Pagnotto LD, Elkins HB, Bayka I. Oral administration of edathamil calcium disodium (calcium<br />
disodium versenate). AMA Archives of Ind. Health. 1958; 17:29-33 (Jan.). (P1943)<br />
83. Parigi A, Rasetti L. Action of orally administered Ca<strong>EDTA</strong> on the metabolism of the porphyrinic<br />
precursors in lead poisoning. Lavoro e Medicina 16. 1962; 3:44-50. (2452)<br />
84. Peters HA, Eichman PL, Price JM, Kozelka FL, Reese HH. Abnormal copper and trytophan<br />
metabolism and chelation therapy in anticonvulsant drug intolerance. Diseases Nervous System. 1966;<br />
27(2):97-107. (CA64:16509c)<br />
85. Petrovic LJ, Stankovic M, Savicevic M, Poleti D. Our experiences with calcium disodium edathamil.<br />
Proc. 13th Int. Congr. on Occup. Health July 25-29, 1960. 1961; pp 338-341. (2176)<br />
86. Pilat L, Moscovici B, Iorga M. CaNa2<strong>EDTA</strong> treatment in mercury intoxication. Proc. 13th Int. Congr.<br />
Occup. Health, 1960. 1961; p. 341-343.<br />
87. Prevot PA, Sulotto F, Poli G, Parigi A. Environmental lead pollution and the principal biological<br />
indexes for evaluating the risk of lead poisoning. Lav. Um. 1969; 21(5):200-209. (CA72)<br />
88. Reinl W. Prophylaxis of lead workers with orally administered Ca2<strong>EDTA</strong>. Zentralblatt fur<br />
Arbeitsmedizin und Arbeitsschutz. 1956; 6:5-8 (Jan.). (1709)<br />
89. Reinl W. Modern therapy of lead intoxication. Regensburger Jahrbuch fur Hrztliche Fortbildung.<br />
1959/60; 8:(8 pp). (2184)<br />
90. Roxburgh RC, Haas L. The diagnostic importance of glycosuria in lead poisoning in childhood. Arch<br />
Dis in Childhood. 1959; 34:70-73 (Feb.). (2957)<br />
91. Selander S. Treatment of lead poisoning. A comparison between the effects of sodium calcium-edetate<br />
and penicillamine administered orally and intravenously. Brit J Indust Med. 1967; 24:272-281.<br />
92. Bell RF, Gilliland JC, Boland JR, Sullivan BR. Effect of oral edathamil calcium-disodium on urinary<br />
and fecal lead excretion. Comparative excretory studies with intravenous therapy. AMA Arch Ind Health.<br />
1956; 13:366-371 (Apr.). (1642)<br />
93. Bersworth FC, Rubin M. Prophylactic calcium chelate compositions for heavy metal poisoning. U.S.<br />
Patent. 1959; 1,875,129 (Feb. 24), to Dow Chemical Co. From Chemical Abstracts 53:10672. (1982)
94. Bersworth FC, Rubin M. Organo-metallic detoxicants. U.S. Patent. 1955; 2,698,823 (Jan. 4) to F.C.<br />
Bersworth. From Chemical Abstracts 49:Abst. No. 4244. (1552)<br />
95. Bjarnason I, Peters TJ, Veall N. A persistent defect in intestinal permeability in coeliac disease<br />
demonstrated by 51Cr-labelled <strong>EDTA</strong> absorption test. Lancet. 1983; 1:323-325.<br />
96. Blomquist L, Bark T, Hedenborg G, Norman A. Evaluation of lactulose/mannitol and 51Crethylenediaminetetraacetic<br />
acid/14C-mannitol methods for intestinal permeability. Scand. J Gastro. 1997;<br />
32(6):805-812. (BA 104)<br />
97. Blumer W, Reich T. Leaded gasoline - A cause of cancer. Environment Int. 1980; 3:465-471.<br />
98. Blumer W. Calcium-disodium-<strong>EDTA</strong> treatment for cardiovascular symptoms. Plzen Lek Sborn Suppl.<br />
1990; 62:157-159.<br />
99. Cann HM, Verhulst HL. Edathamil calcium-sodium (<strong>EDTA</strong>) in lead poisoning. Tennessee Ind. Hygiene<br />
News 15. 1958; 1:3-4. (2936)<br />
100. Cho SS, Mejia L, Morel L, Samuel-Fernando P. Cooked cereal ingredient-containing products<br />
fortified with <strong>EDTA</strong>/iron compositions and methods for use. PCT Int. Appl. WO 99 05,920, 1999, US Appl.<br />
54,428 1997, 24 pp. (CA)<br />
101. Cowan TKJ, Phillips GD, Bragg DB. Effect of dietary <strong>EDTA</strong> on the ability of chicks to tolerate<br />
sodium chloride in the water. Canadian J Animal Sci. 1971; 51(3):633-637. (NA42)<br />
102. Engstroem B, Norin H, Jawait M, Ingman F. Influence of different cadmium-<strong>EDTA</strong> complexes on<br />
distribution and toxicity of cadmium in mice after oral or parenteral administration. Acta Pharmacol.<br />
Toxicol. 1980; 46(3):219-234. (CA)<br />
103. Gehres RF, Raymond S. A new chemical approach to the solution of urinary calculi. J Urol. 1951;<br />
65:474-483. (CA47:8241c)<br />
104. Greig JB. Sodium iron ethylenediamine tetraacetic acid (<strong>EDTA</strong>). WHO Food Addit. Serv. 2000;<br />
44:105-111 (Safety Evaluation of Certain Food Additives and Contaminants). (CA) A review with 9 refs.<br />
on toxicity of NaFe<strong>EDTA</strong>, including acute and short-term toxicity, genotoxicity, developmental toxicity<br />
and food and nutritional toxicity.<br />
105. Harishima S, Tsuchiya K, Kondo H, Motouchi M, Sakaguchi T, Mori A. Therapy and prevention of<br />
lead poisoning with calcium versenate. Keio J. Med. 7. 1958; 93-105. (1914)<br />
106. Hathcock JN, Hill CH, Matrone G. Vanadium toxicity and distribution in chicks and rats. J. Nutr.<br />
1964; 82(1):106-110. (CA60:12576g)<br />
107. Hurrell RF, Ribas S, Davidsson L. NaFe3+<strong>EDTA</strong> as a food fortificant: influence on zinc, calcium and<br />
copper metabolism in the rat. British J Nutr. 1994; 71(1):85-93. (NA64)<br />
108. Kojima S, Kiyozumi M, Matsumoto S, Yamamoto M, Nakamura C, Niho K. Studies on poisonous<br />
metals. III. Effects of chelating agents on gastrointestinal absorption, distribution, and excretion of<br />
cadmium chloride in rats. Eisei Kagaku. 1977; 23(1):43-47. (CA)<br />
109. Krari N, Allain P. Effects of three chelating agents, <strong>EDTA</strong>, NTA, and TPP, on the concentration of<br />
elements in rat tissues. Biol. Trace Elem. Res. 1991; 29(2):125-131. (CA)
110. Makashev KK. Effect of calcium and disodium salts of ethylenediaminetetraacetic acid on lead<br />
absorption, accumulation, and excretion from the system after lead intoxication. Trudy Inst Kraevol<br />
Patologil, Akademiya Nauk Kazakhskoi SSR. 1962; 10:180-189. (1008)<br />
111. Madsen JL, Scharff O, Rabol A, Krogsgaard OW. Relationship between small-intestinal transit rate<br />
and intestinal absorption of 14C-labelled mannitol and 51Cr-labelled ethylenediamine-tetraacetic acid in<br />
healthy subjects. Scand. J Gastro. 1996; 31(3):254-259. (NA66)<br />
112. MacPhail AP, Bothwell TH, Torrance JD, Derman DP, Bezwoda WR, Charlton RW, Mayet F. Factors<br />
affecting the absorption of iron from Fe(III)<strong>EDTA</strong>. British J Nutr. 1981; 45(2):25-227. (NA52)<br />
113. Merville R, Dequidt J, Fontaine G. Ambulatory treatment of occupational lead poisoning by calcium<br />
disodium edetic acid. Lille Med. 4. 1959; 5:291-293. (2035)<br />
114. Stankovic M, Petrovic LJ, Poleti D. Application of Ca2<strong>EDTA</strong> (dicalcium ethylenediaminetetraacetate)<br />
for the diagnosis of lead poisoning. Acta Pharm. Jugoslav. 1960; 10:155-159. (2202) The<br />
compound was administered orally to 24 printers, 18 persons with severe Pb poisoning, and 8 controls with<br />
no Pb exposure. The upper limit of Pb excretion in urine after 3 g Ca<strong>EDTA</strong> was 0.340 mg/24 hr.<br />
115. Suso FA, Edwards Jr HM. Influence of various chelating agents on absorption of cobalt-60, iron-59,<br />
manganese-54, and zinc-65 by chickens. Poultry Sci. 1968; 47(5):1417-1425. (CA70)<br />
116. Vozar L. The action of complexon 3 on the copper balance and level in the organism after oral<br />
administration. J'harmazie. 1959; 14:459-466. (CA54:7892d)<br />
117. Nielsen FH, Sunde ML, Hockstra WG. Effect of some dietary synthetic and natural chelating agents<br />
on the zinc-deficiency syndrome in the chick. J Nutr. 1966; 89(1):35-42. (CA65:14176h)<br />
118. Pedinelli M, Stringari M. Observations on the treatment "per os" with chelating agents in tetraethyl<br />
lead production workers. Rassegna di Medicina Industriale. 1959; 28:514-525 (Nov.-Dec.) (2048)<br />
119. Preda N, Niculescu T, Rafaila E. The treatment of lead intoxication with chelating agents. Igiena<br />
(Bucharest)13. 1964; 3:233-242. (2784) Treatment of Pb-poisoned patients in the Clinic for Occupational<br />
Diseases, Bucharest, with iv injections of 2 g CaNa2<strong>EDTA</strong>/day for 2-20 days markedly increased urinary<br />
excretion of Pb. Oral doses of 4-6 g <strong>EDTA</strong>/day were less effective.<br />
120. Sapeika N. Actions of lead ethylenediaminetetraacetic acid (<strong>EDTA</strong>) complex. Arch. Intern.<br />
Pharmacodynamie. 1955; 101:488-494. (CA49:14168e)<br />
121. Savicevic M, Petrovic LJ. New views on the treatment of occupational lead poisoning. Vojnosanitetski<br />
Pregled. 1964; 21:173-177. (2804)<br />
122. Svicevic M, Petrovic L, Stankovic M, Djordjevic S. Experiences with CaNa2<strong>EDTA</strong> (mosatil bayer) in<br />
chronic Pb exposure. Zentralblatt fur Arbeitsmedizin und Arbeitsschutz. 1959; 9:6-12 (Jan.) (2062)<br />
123. Rubin M. Design of chelates for therapeutic objectives. Fed. Proceed. 20, Suppl. 10. 1961; 2:149-157<br />
(Sept.) (2327)<br />
124. Rosenman RH, Smith MK. The effect of certain chelating substances, salts of ethylenediaminetetraacetic<br />
acid (<strong>EDTA</strong>), upon cholesterol metabolism in the rat. J Clin. Invest. 1956; 35:11-19.<br />
(CA50:6676b)
125. Roldan M, Suarez CL, Perdomo GM, Camarero SC, Escobar CH. Study of intestinal permeability in<br />
celiac disease with 51 Cr-<strong>EDTA</strong>. Acta Gastroenterol Latinoam. 1994; 24:37-40.<br />
126. Proescher F. Anti-coagulant properties of ethylene bisiminodiacetic acid. Proc. Soc. Exptl. Biol. Med.<br />
1951; 76:619-620.<br />
127. Pommier SA, Lapierre H, de Passille AM, Gariepy C. Control of the bioavailibility of iron in heavy<br />
veal production by different feeding management systems: use of Ca-<strong>EDTA</strong> as an iron chelating agent. Can.<br />
J Anim. Sci. 1995; 75(1):37-44. (CA)<br />
128. Aamoth HL, Butt FJ. Maintaining food quality with chelating agents. Ann. N.Y. Acad. Sci. 1960;<br />
88:526-531. (CA55:12687e) Ethylenediaminetetraacetic acid (<strong>EDTA</strong>) and its di- or tetra-Na salts alleviate<br />
a wide variety of problems caused by trace-metal ions in food products.<br />
129. Ainsworth M, Eriksen J, Waever Rasmussen J, Schaffalitzky De Muckadell OB. Intestinal<br />
permeability of 51Cr-labelled ethylenediaminetetraacetic acid in patients with Crohn's disease and their<br />
healthy relatives. Scand. J Gastroenterol. 1989; 24:993-998.<br />
130. Albahary C, Truhaut R, Boudene C. The diagnosis of lead poisoning following urinary elimination of<br />
lead induced by calcium disodium versenate. Archiv. Maladies Professionnelles de Med. Du Travail et de<br />
Securite Sociale. 1958; 19:121-131 (Mar.-Apr.). (1883)<br />
131. Albahary C, Truhaut R, Boudene C. Lead poisoning and detoxication by calcium versenate: new<br />
observations. Archiv. Maladies Professionnelles de Med. Du Travail et de Securite Sociale. 1957; 18(1):40-<br />
46. (1739)<br />
132. Bastenier H. Considerations on the diagnosis and treatment of occupational lead poisoning. Acta<br />
Clinica Belgica. 1963; 18:144-151. (2501)<br />
133. Bartolozzi O, Zurlo N. Effects of the preventive treatment with calcium versenate in workers exposed<br />
to lead. Medicina del Lavoro. 1960; 51:607-611 (Oct.). (2094)<br />
134 . Barnes WS, Weisburger JH. Formation of mutagens in cooked foods. VI. Modulation of mutagen<br />
formation by iron and ethylenediaminetetracetic acid (<strong>EDTA</strong>) in fried beef. Cancer Lett. 1984; 24(2):221-<br />
226. (CA)<br />
135. Atkinson J, Vohra P, Kratzer FH. Effect of available dietary zinc on the utilization of protein by the<br />
chick and Japanese quail. Brit. J Nutr. 1972; 27(3):461-466. (CA77) [By using chicks and quail to measure<br />
net protein utilization (NPU) and true digestibility of N of isolated soybean protein and a mixt. of gelatin<br />
and casein in Zn-deficient diets, it was found that NPU for both was increased when the diets were<br />
supplemented with Zn or di-Na <strong>EDTA</strong>, as was the true digestibility of N of isolated soybean protein.]<br />
136. Ashmead H, Mencimer FR. Methods for controlling and treating renal calculi. U.S. 3,281,322 (Cl.<br />
167-55), Oct. 25, 1966. Appl. September 11, 1961. (CA66)<br />
137. Basinger MA, Jones MM, Holscher MA, Vaughn WK. Antagonists for acute oral cadmium chloride<br />
intoxication. J Toxicol. Environ. Health. 1988; 23(1):77-89. (CA)<br />
138. Ashmead H, Mencimer FR. Drugs for urinary calculi. U.S. 3,184,381 (Cl. 167-53), May 18, 1965.<br />
Appl. Feb. 28, 1961; 3 pp. (CA63:5459c)
139. Ashmead H, Mencimer FR. Drugs containing sequestering and chelating agents for preventing<br />
lithiasis and atherosclerotic plaques. Brit. 1,132,233 (Cl. A 61k) 30 Oct. 1968. Appl. 22 Oct. 1965, 21 pp.<br />
(CA70)<br />
140. Bartolozzi O. Report of nine year of prophylactic treatment with calcium versenate in a storage battery<br />
plant. Medicina del Lavoro. 1964; 55:315-316 (Apr.). (2668)<br />
141. Batskor IA, Timar M. The treatment of lead poisoning with Ca<strong>EDTA</strong> per os. Egeszsegtudomany 5.<br />
1961; 3:259-263. (2230)<br />
142. Belknap EL, Perry MC. Treatment of inorganic lead poisoning with edathamil calcium-disodium.<br />
AMA Archiv. Ind. Hygiene Occup. Med. 1954; 10:530-547 (Dec.). (1463)<br />
143. Batskor IA, Kovacs I, Pasceri I. The effectiveness of Ca<strong>EDTA</strong>-treatment in the prophylaxis of lead<br />
intoxication. Zentralblatt fur Arbeitsmedizin Arbeitsschutz. 1961; 11:261-264 (Nov.) (2229)<br />
144. Bonazzi P, Lanzoni J, Marcucci F, Mussini E. Pharmacokinetic studies of ethylenediamine-tetraacetic<br />
acid (<strong>EDTA</strong>) in rats. Eur. J Drug Metab. Pharmacokinet. 1981; 6:21-26.<br />
145. Bickel H, Neale FC, Hall G. Clinical and biochemical study of hepatolenticular degeneration<br />
(Wilson's disease). Quart. J Med. 1957; 26:527-528. (CA52:3994f).<br />
146. Blomquist L, Bark T, Hedenborg G, Svenberg T, Norman A. Scand. J Gastroenterol. 1993; 28:274-<br />
280.<br />
147. Brykalski D, Wronowa B. The effect of oral administration of <strong>EDTA</strong> on the absorption and<br />
elimination of lead administered in the same manner. Medycyna Pracy 14. 1963; 4:313-320. (1044)<br />
148. Brykalski D, Bolanowska W. Further studies on the effect of orally administered <strong>EDTA</strong> on lead<br />
absorption and excretion. Medycyna Pracy 15. 1964; 3:133-138. (1111)<br />
149. Buescher R, Hamilton C. Protection of cucumber pickle quality of CaNa2 <strong>EDTA</strong>. J Food Qual. 2000;<br />
23(4):429-441. (CA)<br />
150. Brul S, Coote P. Preservative agents in foods. Mode of action and microbial resistance mechanisms.<br />
Int. J Food Microbiol. 1999; 50(1-2):1-17. (CA)<br />
151. Byers RK. Review of the literature and report on 45 cases. Pediatrics. 1959; 23:585-603 (March).<br />
(2951)<br />
152. Cranton EM. What about oral chelation. J Advancement Med. 1999; 12:237-239.<br />
153. Comar C, Wasserman RH, Twardock AR, Lengemann FW. Effect of various substances on secretion<br />
of radiostrontium into milk. Health Phys. 1966; 12(12):1661-1669. (CA66)<br />
154. David OJ, Hoffman SP, Sverd J, Clark J, Voeller K. Lead and hyperactivity. Behavioral response to<br />
chelation: a pilot study. Am. J Psychiat. 1976;133:1155-1158.<br />
155. Foreman H. Use of chelating agents in treatment of metal poisoning (with special emphasis on lead).<br />
Fed. Proceed. 20, Suppl. 10. 1961; 2:191-196. (2256)
156. Food and Drug Administration, HHS (USA). Food additives permitted for direct addition to food for<br />
human consumption; calcium disodium <strong>EDTA</strong> and disodium <strong>EDTA</strong>. Fed. Regist. 2000; 65(153):48377-<br />
48379. (CA)<br />
157. Freedman L, Blitz M, Sabine DB, Eigen E (to U.S. Vitamin & Pharmaceutical Corp.). Stable vitamin<br />
B12 solutions. U.S. 2,939,821, June 7, 1960. (CA54:20101i)<br />
158. Escobar H, Perdomo M, Vasconez F, Camarero C, del Olmo MT, Suarez L. Intestinal permeability to<br />
51Cr-<strong>EDTA</strong> and orocecal transit time in cystic fibrosis. J Pediat. Gastroenterol. Nutr. 1992; 14:204-207.<br />
159. Dizon GD, Anselmo JE, Almonte JB, Aquino R, Navarro A. Study of health hazards in the storage<br />
battery manufacture in the Philippines. Excerpta Medica Foundation. 1964; Vol. III, pp. 1004-1010. (2688)<br />
160. Edwards PJ, Morwood K. Pharmaceutical compositions against gastric disorders containing<br />
bacteriocins. PCT Int. Appl. WO 92 18,143 (Cl. A61K37/02), 29 Oct. 1992. GB Appl. 91/8,129, 15 Apr.<br />
1991, 15 pp. (CA)<br />
161. Domingo JL, Llobet JM, Corbella J. The effects of <strong>EDTA</strong> in acute cobalt intoxication in rats. Toxicol.<br />
Eur. Res. 1983; 5(6):251-255. (CA)<br />
162. Eisenberg GM, Weiss W, Flippin HF. Effect of ethylenediaminetetraacetic acid and ascorbic acid on<br />
tetracycline blood serum concentrations. J Lab. Clin. Med. 1958; 52:895-898. (CA53:3499f)<br />
163. Dunkley WL, Franke AA, Robb J, Ronning M. Influence of dietary copper and ethylenediaminetetraacetate<br />
on copper concentration and oxidative stability of milk. J Dairy Sci. 1968; 51(6):863-866.<br />
(CA69)<br />
164. Davin JC, Forget P, Mahieu PR. Increased intestinal permeability to (51 Cr) <strong>EDTA</strong> is correlated with<br />
IgA immune complex-plasma levels in children with IgA-associated nephropathies. Acta Paediat. Scand.<br />
1988; 77:118-124.<br />
165. De Freitas Tavares J, Porto AL. The use of chelating agents in the treatment of lead poisoning. Jornal<br />
do Medico (Porto). 1961; 44:925-929 (Apr. 29). (2250)<br />
166. Davis PS, Deller DJ. Effect of orally administered chelating agents <strong>EDTA</strong>, DTPA, and fructose on<br />
radioiron absorption in man. Australas. Ann. Med. 1967; 16(1):70-74. (CA67)<br />
167. Davidsson L, Walczyk T, Zavaleta N, Hurrell RF. Improving iron absorption from a Peruvian school<br />
breakfast meal by adding ascorbic acid or Na2<strong>EDTA</strong>. Am. J Clin. Nutr. 2001; 73(2):283-287. (CA)<br />
168. Fritz JC, Pla GW, Boehne JW. Influence of chelating agents on utilization of calcium, iron and<br />
manganese by the chick. Poultry Sci. 1971; 50(5): 1444-1450. (CA75)<br />
169. Gordon GF. <strong>EDTA</strong> and chelation therapy: history and mechanisms of action - an update. Clin. Pract.<br />
Altern. Med. 2001; 2:36-45.<br />
170. Gordon GF. <strong>EDTA</strong> safe in treating patients with mercury toxicity. Townsend Lett. For Doctors &<br />
Patients. 1997; 163, 164:102.<br />
171. Gordon G. Oral chelation for improved heart function. Life Enhancement. 1997 (Apr.); p. 7-15.<br />
172. Gordon GF. Oral chelation: the other side of the story. Clin. Pract. Altern. Med. 2000; 1:113-115.
173. Gordon GF. Oral chelation with <strong>EDTA</strong>. J Holistic Med. 1986; 8:79-80.<br />
174. Guepin J. A case of occupational lead poisoning. Ouest Metical. 1964; 17:570-573 (May 10). (2719)<br />
175. Hutchinson HE, Stark JM. The anemia of lead poisoning. J Clin. Path. 1961; 14:548-549 (Sept.).<br />
(2277)<br />
176. Horiuchi K, Noma H, Asano I, Hashimoto K. Studies on the industrial lead poisoning. An<br />
experimental study of lead intake in human beings through the respiratory tract. Osaka City Med. J 8. 1962;<br />
2:151-169. (2413)<br />
177. Hurrell RF, Reddy MB, Burri J, Cook JD. An evaluation of <strong>EDTA</strong> compounds for iron fortification of<br />
cereal based foods. Br. J Nutr. 2000; 84(6):903-910. (CA)<br />
178. Hublet P. Comments relating to the preventive administration of <strong>EDTA</strong> for the prevention of lead<br />
poisoning. Third World Cong. On Prevention of Occup. Risks. 1961:492. (2275)<br />
179. Itoh H, Yamaguchi T, Yamasawa S. Inhibition of hematopoietic action of iron by ethylenediaminetetraacetate<br />
(<strong>EDTA</strong>). Yokohama Med. Bull 13. 1962; 1:9-16. (CA57:7863b)<br />
180. Jenkins RT, Ramage JK, Jones DB, Collins SM, Goodacre RL, Hunt RH. Small bowel and colonic<br />
permeability to 51Cr-<strong>EDTA</strong> in patients with active inflammatory bowel disease. Clin. Invest. Med. 1988;<br />
11:151-155.<br />
181. Karunajeewa H. Influence of high calcium rearing diets, Christmas Island phosphate and<br />
ethylenediaminetetraacetic acid on the laying performance of White Leghorn X Australorp hens. Aust. J<br />
Exp. Agric. Anim. Husb. 1977; 17(89):944-948. (CA)<br />
182. Karunajeewa H. Effect of some feed additives on the performance of broiler chicks fed diets<br />
containing high levels of meat and bone meal. Aust. J Exp. Agric. Anim. Husb. 1976; 16(82):685-690.<br />
(CA)<br />
183. LaChance LE. Ingestion of ethylenediaminetetraacetic acid and the effect on life span of irradiated and<br />
control Habrobracon females. Nature. 1958; 182:870-871. (CA53:4587h)<br />
184. Kimmel CA. Effect of route of administration on the toxicity and teratogenicity of <strong>EDTA</strong> in the rat.<br />
Toxicol. 1977; (40(2):299-306. (CA)<br />
185. Leigh MJ, Miller DD. Effects of pH and chelating agents on iron binding by dietary fiber: implications<br />
for iron availability. Am. J Clin. Nutr. 1983; 38(2):202-213. (CA)<br />
186. Lilis R, Fischbein A. <strong>Chelation</strong> therapy in workers exposed to lead. A critical review. JAMA. 1976;<br />
235:2823-2824.<br />
187. McGivern J, Mason J. The effect of chelation on the absorption of cadmium from rat intestine in vivo.<br />
J Comp. Pathol. 1979; 89(2):293-300. (CA)<br />
188. Sprague G. The effect of dietary administration of ethylenediamine-tetraacetic acid upon the mineral<br />
content of mouse tissues. Trans. Nebr. Acad. Sci. 1976; 3:61-68. (CA)<br />
189. Herta S. Studies of the effect of chelating agents in man. Ann. N.Y. Acad. Sci. 1960; 88:435-449.<br />
(CA55:2903c)
190. Sigthorsson G, Jacob M, Wrigglesworth J, Somasundaram S, Tavares I, Foster R, Roseth A, Rafi S,<br />
Mahmud T, Simpson R, Bjarnason I. Scand. J Gastroenterol. Comparison of indomethacin and nimesulide,<br />
a selective cyclooxygenase-2 inhibitor, on key pathophysiologic steps in the pathogenesis of nonsteroidal<br />
anti-inflammatory drug enteropathy in the rat. Scand. J. Gastroenterol. 1998; 33(7):728-735. (CA)<br />
191. Solomons N, Viteri F, Pineda O, Jacob R. The effects of NaFe<strong>EDTA</strong> and ascorbic acid (AA) on zinc<br />
bioavailability in man. Fed. Proceed. 1979; 38(3, I):704. (NA49)<br />
192. Sullivan TJ. Effects of metallic edetates on the growth and blood formation of rats. Arch. Intern.<br />
Pharmacodynamie. 1960; 124:225-236. (CA54:23068b)<br />
193. Vohra P, Bond DC. The effect of various levels of dietary <strong>EDTA</strong> on the mineral contents of some<br />
tissues of Coturnix Coturnix Japonica. Poultry Sci. 1970; 49:565-568. (NA41)<br />
194. Vozar L, Bobek P. The influence of complexon 3 on the composition of the blood serum protein<br />
spectrum in rats and guinea pigs. Pharmazie. 1958; 13:704-707. (CA53:12473d)<br />
195. Vohra P, Heil JR. Growth-promoting properties of crude soybean phospholipids. Poultry Sci. 1969;<br />
48(5):1661-1667. (CA72)<br />
196. Will JJ, Vilter RW. The absorption and utilization of an iron chelate in iron-deficient patients. J Lab.<br />
Clin. Med. 1954; 44:499-505. (CA49:1961g) Ferric sodium ethylenediaminetetraacetate (I) was given<br />
orally, and the absorption and utilization were compared with oral FeSO4 (II). I and II were labeled with<br />
isotopic Fe. I was absorbed to the same extent as II (about 6%). No detectable amt. was excreted in the<br />
urine. I and II produced identical reticulocyte responses. The observations suggested that I is split in the<br />
gastrointestinal tract into ionized Fe and that this is absorbed in the usual manner.<br />
197. Yokel RA, Kostenbauder HB. Assessment of potential aluminum chelators in an octanol/aqueous<br />
system and in the aluminum-loaded rabbit. Toxicol. Appl. Pharmacol. 1987; 91(2):281-294. (CA)<br />
198. Zizine LA. Action of a chelating agent on thyroid activity of the rat. Compt. Rend. Soc. Biol. 1958;<br />
152:31-35. (CA52:20623a) Addn. of 0.5% of di-Na Ca ethylenediaminetetraacetate to the diet of rats<br />
resulted in a significant decrease in activity of the thyroid.<br />
199. Zarembski PM, Hodgkinson A. Factors influencing the urinary excretion of oxalic acid in man. Clin.<br />
Chim. Acta. 1969; 25(1):1-10. (CA71)<br />
200. Zorina LA, Vanshtein IA. Therapeutic value of complexing compounds in chronic lead poisoning.<br />
Gigiena Truda Professional'nye Zabolevaniya 3. 1959; 1:7-11. (2085)<br />
201. Zambrano A, Mangieri A, Silvestroni A. Calcium salt of versene in experimental lead poisoning.<br />
(Urinary and fecal lead excretion. Electrolytes and alkaline phosphatase in the blood). Folia Medica<br />
(Naples). 1955; 38:813-837 (Aug.). (655)<br />
202. Parks PF, Salmon WD. An evaluation of factors affecting survival of choline deficient weaning rats<br />
with special emphasis on dietary sodium. J Nutr. 1967; 91(3): part I, 307-313. (CA67)<br />
203. Morgan JM. <strong>Chelation</strong> therapy in lead nephropathy. South Med. J. 1975; 68:1001-1006. (CA)<br />
204. Oberleas D, Muhrer ME, O'Dell BL. Dietary metal-complexing agents and zinc availability in the rat.<br />
J Nutr. 1966; 90:56-62. (NA37)
205. O'Dell BL, Emery M, Xia J, Browning JD. In vitro addition of glutathione to blood from zincdeficient<br />
rats corrects platelet defects: impaired aggregation and calcium uptake. J Nutr. Biochem. 1997;<br />
8(6):346-350. (CA)<br />
206. Parigi A, Giovanelli E. Side effects of oral treatment with CaNa2<strong>EDTA</strong>. Lavoro e Medicina 16. 1962;<br />
3:48-51. (2451)<br />
207. Owen AA, Peo Jr ER, Cunningham PJ, Moser BD. Effect of EDT on utilization of dietary zinc by G-F<br />
swine. J Animal Sci. 1973; 37(2):470-478. (NA44)<br />
208. Aabakken L. 51Cr-Ethylenediaminetetraaceteic acid absorption test. Methodologic aspects. Scand. J<br />
Gastroenterol. 1989; 24:351-358.<br />
209. Abels J, Woldring MG, Nieweg HO, Faber JG, de Vries JA. Ethylenediaminetetraacetate (<strong>EDTA</strong>) and<br />
the intestinal absorption of vitamin B12. Nature. 1959; 183:1395-1396. (CA55:1839e)<br />
210. Albahary C. Prevention of lead poisoning. Third World Congress on the Prevention of Occupational<br />
Risks, Paris, France. 1961;491. (2222)<br />
211. Alberts JC, Lang JA, Reyes PS, Briggs GM (Dept. Nutr. Sci., Univ. California, Berkeley). Zinc<br />
requirement of the young guinea pig. J Nutr. 1977; 107(8):1517-1527. (CA)<br />
212. Ali RAM, Evans JL (Rutgers State Univ., New Brunswick, NJ). Body composition in the growing rat<br />
as affected by dietary lactose, calcium, buffering capacity and <strong>EDTA</strong>. J Anim. Sci. 1971; 33(4):765-770.<br />
(CA76)<br />
213. Ali R, Evans JL (Coll. Agr. Cairo Univ., Giza, UAR). Effect of dietary calcium buffering capacity,<br />
lactose and <strong>EDTA</strong> on pH of and calcium absorption from gastrointestinal segments in the growing rat. J<br />
Nutr. 1967; 93(3):273-279. (BA49)<br />
214. Mohamed-Ali RA (Rutgers State Univ., New Brunswick, NJ). Effects of dietary calcium level,<br />
buffering capacity, lactose, and <strong>EDTA</strong> (ethylenediaminetetraacetic acid) on calcium metabolism in the<br />
growing rat. Diss. Abstr. B. 1967; 27(11):3776-3777. University Microfilms (Ann Arbor, Mich.), Order No.<br />
67-5271, 161 pp. (CA68)<br />
215. Amery WK, Forget PP. The role of the gut in migraine: the oral 51-Cr <strong>EDTA</strong> test in recurrent<br />
abdominal pain. Cephalalgia. 1989; 9:227-229.<br />
216. Alsmeyer WL. Influence of salts of ethylenediaminetetraacetic acid on the tryptophan load test in<br />
pyridoxine-deficient swine. Diss. Abstr. B. 1967; 27(11):3730. Univ. Microfilms (Ann Arbor, Mich.),<br />
Order No. 67-6541, 99 pp.<br />
217. Anderson WA, Cole MB, Gould GW, Jones MV. Antibacterial food additives for prevention of<br />
growth of Listeria and other bacteria. Eur. Pat. Appl. EP 466,244 (Cl. A23L3/3571), 15 Jan 1992, EP Appl.<br />
90/307,694, 13 Jul 1990; 13 pp. (CA)<br />
218. Anon. Avoid "chelation therapy" pills. FDA Consumer. Sept. 1985:19(7):34.<br />
219. Anon. Calcium disodium ethylenediaminetetraacetate: permitted addition to certain foods. Federal<br />
Register. 1960; 25:7316. (CA54:25345b)<br />
220. Anon. Black-eye peas, potatoes: order listing disodium <strong>EDTA</strong> and calcium disodium <strong>EDTA</strong> as<br />
optional ingredients. Federal Register, cf. CA 61, 12544d. Nov. 1964; 29:14984-14985. (CA62: 3316c)
221. Anon. The complexities of <strong>EDTA</strong>. Food Cosmet. Toxicol. 1972; 10:697-700.<br />
222. Anon. Disodium <strong>EDTA</strong> (Disodium ethylenediaminetetraacetate). Federal Register, cf. CA 57, 12964d.<br />
Nov. 1962; 27:11257. (CA58:3821f) [The previous regulation under the Federal Food, Drug, and Cosmetic<br />
Act is extended to permit the use of a max. of 100 p.p.m. of the title compd. as a color preservative in<br />
frozen white potatoes.]<br />
223. Anon. Dressings for foods. Food additives. Calcium disodium ethylenediamine-tetraacetate, disodium<br />
ethylenediaminetetraacetate; order affecting nomenclature and listing as optional ingredients of mayonnaise,<br />
french dressing, and salad dressing. Oleomargarine; order amending identity standard to permit calcium<br />
disodium ethylenediaminetetraacetate as optional preservative ingredient. Federal Register cf. CA 55,<br />
14742f; 58, 3821f, 59, 14495d. Feb. 12, 1964; 29:2382-2384. (CA60:13801c)<br />
224. Anon. Food additives. Boiler water additives. Federal Register, cf. CA 58, 10661b. Oct. 16, 1964;<br />
29:14224. (16697c) [Tetrasodium <strong>EDTA</strong> may be used under the Federal Food, Drug and Cosmetic Act as a<br />
boiler water additive in the prepn. of steam that will contact food.]<br />
225. Anon. Food additives. Adhesives. Federal Register, CF. ca 59, 13261c. Dec. 31, 1963; 28:14493.<br />
(CA60:6131a) [The previous regulation under the Federal Food, Drug, and Cosmetic Act is revised to<br />
permit the use of ferric salts of ethylenediaminetetraacetic acid in food-packaging adhesives.]<br />
226. Anon. Food additives. Calcium disodium <strong>EDTA</strong>. Federal Register, cf. CA 62, 3316c. May 21, 1965;<br />
30:6915-6916. (CA63:6236e) [The previous regulation under the Federal Food, Drug, and Cosmetic Act<br />
was revised to provide for the use of a max. of 310 ppm. of Ca di-Na <strong>EDTA</strong> as a color stabilizer in canned,<br />
cooked, and dried lima beans.]<br />
227. Anon. Food additives. Calcium disodium <strong>EDTA</strong>. Federal Register, cf. CA 55. August 29, 1961;<br />
26:8072. (CA55:23853h) [One hundred p.p.m. of the title compd. may be used under the Food, Drug, and<br />
Cosmetic Act in pecan pie fillings to prevent discoloration.]<br />
228. Anon. Food additives. Calcium disodium ethylenediaminetetraacetate. Federal Register, cf. CA 55,<br />
4811c. Apr. 4, 1961; 26:2780. (CA55:10737c) [The previous regulations under the Food, Drug, and<br />
Cosmetic Act are revised to permit 275 p.p.m. of the title compd. (calcd. as anhyd. compd.) in or on cooked,<br />
canned crabmeat and 250 p.p.m. in or on cooked, canned shrimp to retard struvite formation and to promote<br />
color retention.]<br />
229. Anon. Food additives. Calcium disodium <strong>EDTA</strong>. Federal Register, cf. CA 66:94047h. May 2, 1967;<br />
32:6686. (CA67) [The title compd. may be used under the Federal Food, Drug and Cosmetic Act at a max.<br />
level of 200 ppm. to stabilize the color of canned mushrooms.]<br />
230. Anon. food additives. Calcium disodium ethylenediaminetetraacetate. Federal Register, cf. CA 55,<br />
10737c. July 13, 1961; 26:6271-6272. (CA55:20243a)<br />
231. Anon. Food additives. Chelating agents. Federal Register, cf. CA 55, 20246a. Jan. 12, 1962; 27:339.<br />
(CA56:7755e) [Di-Na ethylenediaminetetraacetate is included under the Fed. Food, Drug, and Cosmetic<br />
Act as a chelating agent in the list of substances that may be used in the manuf. of paper and paperboard<br />
that contacts food.]<br />
232. Anon. Food additives. Calcium disodium <strong>EDTA</strong> (calcium disodium ethylenediaminetetraacetate;<br />
calcium disodium (ethylenedinitrilo)tetraacetate). Federal Register, cf. CA 58, 3822b. Sept. 25, 1963;<br />
28:10377-10378. (CA59:14495e) [The title compd. may be used as a stabilizer of the color of canned clams<br />
under the Federal Food, Drug, and Cosmetic Act at a max. level of 340 p.p.m.]
233. Anon. Food additives. Disodium <strong>EDTA</strong>. Federal Register, cf. CA 62, 3316c. Nov. 25, 1964; 29:15814.<br />
(CA62:7027h) [A max. of <strong>500</strong> ppm. di-Na <strong>EDTA</strong> may be used under the Federal Food, Drug, and<br />
Cosmetic Act in canned strawberry pie filling to promote color retention.]<br />
234. Anon. Food additives. Disodium <strong>EDTA</strong> (Disodium ethylenediaminetetraacetate). Federal Register, cf.<br />
CA 56, 12040a. Aug. 23, 1962; 27:8424. (CA57:12964d) [A max. of 165 p.p.m. di-Na <strong>EDTA</strong> may be used<br />
under the Federal Food, Drug and Cosmetic Act as a preservative in canned kidney beans.]<br />
235. Anon. Food additives. Disodium <strong>EDTA</strong>. Federal Register, cf. CA 60, 13801c. Aug. 28, 1964;<br />
29:12364-12365. (CA61:12544d) [The previous regulation under the Federal Food, Drug, and Cosmetic<br />
Act is revised to permit the use of di-Na <strong>EDTA</strong> to promote color retention in dried banana products (315<br />
p.p.m. max.) used as a component of cereal products and in canned cooked chickpeas (165 p.p.m. max.).]<br />
236. Anon. Food additives. Disodium <strong>EDTA</strong>. Federal Register. June 18, 1965; 30:7895. (CA63:6238b)<br />
[Disodium <strong>EDTA</strong>, min. 99% dihydrate, may be used under the Federal Food, Drug, and Cosmetic Act as a<br />
max. level of 240 ppm. to solubilize trace minerals in aq. solns. which are added to ruminant feeds.]<br />
237. Anon. Food additives. Disodium <strong>EDTA</strong>. Federal Register, cf. CA 71:100539s. Jun 10,<br />
1970;35(112):8930-8931. (CA73) [Di-Na <strong>EDTA</strong> may be used under the U.S. Federal Food, Drug, and<br />
Cosmetic Act in gefilte fish balls or patties in the packaging medium at a max. level of 50 ppm (total wt. of<br />
fish and medium) to inhibit discoloration.]<br />
238. Anon. Food additives. Disodium <strong>EDTA</strong>. Federal Register, cf. CA 67:2133c. Aug 14, 1969;<br />
34(155):13153-13154. (CA71) [The title compd. may be used under the U.S. Federal Food, Drug, and<br />
Cosmetic Act in cooked sausage at a max. level of 36 ppm. as a cure accelerator with Na ascorbate or<br />
ascorbic acid.]<br />
239. Anon. Food additives. Disodium <strong>EDTA</strong>. Federal Register, cf. CA 62:7027h. April 25, 1967; 32:6393.<br />
(CA67) [Di-Na <strong>EDTA</strong> may be used under the Federal Food, Drug, and Cosmetic Act as a sequestrant with<br />
nonnutritive sweeteners designed for use in aq. soln. at a max. level, calcd. as anhyd. Ca di-Na <strong>EDTA</strong>, of<br />
0.1% of the wt. of the dry nonnutritive sweetener.]<br />
240. Anon. Food additives. Disodium <strong>EDTA</strong>. Federal Register, cf. CA 63:6238b. Nov 6, 1968;<br />
33(217):16272. (CA70) [The previous regulation under the US Federal Food, Drug, and Cosmetic Act is<br />
revised to permit the use of di-Na <strong>EDTA</strong> as a solubilizer for trace minerals in aq. solns. in all animal feeds<br />
instead of ruminant feeds.]<br />
241. Anon. Food additives. Disodium <strong>EDTA</strong> (disodium ethylenediaminetetraacetate). Federal Register, cf.<br />
CA 55, 20243a. Jan. 31, 1962; 27:883. (CA56:12040a) [A tolerance of 150 p.p.m. of the title compd. is<br />
established under the Food, Drug, and Cosmetic Act for use with Fe salts as a stabilizer for vitamin B?? in<br />
aq. multivitamin prepns.]<br />
242. Anon. The metabolism of <strong>EDTA</strong>. Fd. Cosmet. Toxicol. 1964; 2:741-745.<br />
243. Appel MJ, Kuper CF, Wouteren RA (Dept of General Toxicology, TNO Nutrition and Food Research,<br />
Zeist, Neth.). 352654b Disposition, accumulation and toxicity of iron fed as iron (II) sulfate or as sodium<br />
iron <strong>EDTA</strong> in rats. Food Chem. Toxicol. 2001; 39(3):261-269. (CA)<br />
244. Asami T, Takhashi M, Andrews JF, Boettcher TE. (Minnesota Mining and Mfg. Co.) 123:349936n<br />
Oral disinfectant for companion animals. US 5,460,802 (Cl. 424-49; A61K7/16). 1995; Appl. 276,531, 18<br />
Jul 1994: 8 pp. (CA)
245. Ashbel SI, Khil RG, Shatrova SP (Inst. Ind. Hyg. and Occupat. Diseases, Gorki). Fate in the organism<br />
of the Ca disodium salt of ethylenediaminetetracetic acid with different modes of introduction. Farmakol. I<br />
Toksikol. 1966; 29(2):235-237. (CA65:6154e)<br />
246. Ballot DE, MacPhail AP, Bothwell TH, Gillooly M, Mayet FG. Fortification of curry powder with<br />
NaFe(111) <strong>EDTA</strong> in an iron-deficient population: initial survey of iron status. Am. J Clin. Nutr. 1989;<br />
49:156-161.<br />
247. Ballot DE, MacPhail AP, Bothwell TH, Gillooly M, Mayet FG. Fortification of curry powder with<br />
NaFe(111) <strong>EDTA</strong> in an iron-deficient population: report of a controlled iron-fortification trial. Am. J Clin.<br />
Nutr. 1989; 49:162-169.<br />
248. Bauer RO, Rullo FR, Spooner C, Woodman E. Acute and subacute toxicity of ethylene diamine<br />
tetraacetic acid (<strong>EDTA</strong>) salts. Fed. Proc. 1952; 11:321.<br />
249. Bautista ZP (Harper Hosp., Detroit, Mich.). Lead poisoning. A review and report of seven cases.<br />
Harper Hosp. Bulletin. 1963; 21:43-55 (Mar.-Apr.). (3016)<br />
250. Belyaev YA. Effect of oral administration of some chelating agents on the excretion of plutonium in<br />
rats. Raspredelenic, Biol. Deistvie, Uskorenic Vyvedeniya Radioaklivn. Izotopov, Sb. Rabol. 1964; 338-<br />
342. (CA62:16608a)<br />
251. Belknap EL. Modern trends in the treatment of lead poisoning. A review of the literature on the use of<br />
edathamil calcium-disodium. J of Occup. Med. 1961; 3:380-391 (Aug.). (2231)<br />
252. Belknap EL. Review of ten years of published experiences of treatment of inorganic lead absorption in<br />
the adult with edathamil or calcium sodium <strong>EDTA</strong>. Proceedings 13th Intl. Congress on Occup. Health, NY,<br />
July 25-29, 1960. 1961; pp. 217-226. (2095)<br />
253. Benard A, Desreumeaux P, Huglo D, Hoorelbeke A, Tonnel A-B, Wallaer B. Increased intestinal<br />
permeability in bronchial asthma. J Allerg. Clin. Immunol. 1996; 97:1173-1178.<br />
254. Benoni C, Prytz H. Effects of smoking on the urine excretion of oral 51Cr <strong>EDTA</strong> in ulcerative colitis.<br />
Gut. 1998; 42:656-658.<br />
255. Berjak J (Johannesburg, S. Africa). Clinical aspects of an outbreak of metallic poisoning at By-<br />
Products Ltd. Proceed. Mine Med. Officers' Assoc. 1963; 43:7-11 (May-June). (2503)<br />
256. Bersin T, Muller A, Schwarz H. Pharmacological action of some inorganic-organic complex<br />
compounds. Arch. Biochem. and Biophys. 1957; 69:507-513. (706)<br />
257. Berstad A, Jorgensen H, Frey H, and Lund EM. Intestinal absorption of calcium from three<br />
commercial calcium preparations in man. Scand. J Gastroenterol. 1976; 11:747-751.<br />
258. Berti T, Ferrari M. Anti-spirochetic action of hydrosoluble organic compounds of bismuth. I.<br />
Infections from Borrelia duttonii in mice. Boll. ist. sieroterap. Milan. 1959; 38:318-323. (CA54:3710g)<br />
259. Berti T, Francheschini V. Chemotherapeutic action of sodium bismuth ethylenediamine-tetraacetate<br />
(Bi-<strong>EDTA</strong>) in experimental infection by Borrelia duttonii. Atti ist. veneto sci. lettere ed arti. Classe sci. mat.<br />
nat. 1957; 115:63-68; cf. C.A. 51, 9939i. (CA53:2477d)<br />
260. Bessman SP, Doorenbos NJ. <strong>Chelation</strong> (editorial). Ann. Intern. Med. 1957; 47:1036-1041.
261. Bezzubov AD, Vasil'eva OG, Khatina AI (Inst. Ind. Hyg. Occup. Dis., Acad. Med. Sci., USSR).<br />
Influence of pectin on the elimination of lead from the body. Gigiena Truda I Prof. Zabolevaniya 4. 1960;<br />
3:32-37. (888)<br />
262. Bi C-P (Chang-Tai Co. Ltd., Taiwan). Use of <strong>EDTA</strong> in foods. Shih P'in Kung Yeh (Hsinchu, Taiwan).<br />
1978; 10(2):23-30. (CA) [A review with no refs. on the application of <strong>EDTA</strong> (60-00-4) in food<br />
processings; the phys. and chem. properties of <strong>EDTA</strong> are also discussed.]<br />
263. Billerbeck FW, Hing FS, Purvis GA (Gerber Products Co.). Infant cereal. U.S. 3,429.711 (Cl. 99-83;<br />
A 231), 25 Feb 1969. Appl. 26 Nov 1965; 2 pp. (CA70)<br />
264. Bjarnason I, O'Morain C, Levi AJ, Peters TJ. Absorption of 51chromium-labeled ethylenediaminetetraacetate<br />
in inflammatory bowel disease. Gastroenterology. 1983; 85:318-322.<br />
265. Bjarnason I, MacPherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology.<br />
1995; 108:1566-1581.<br />
266. Bjarnason I, Goolamali SK, Levi AJ, Peter TJ. Intestinal permeability in patients with atopic eczema.<br />
Brit. J Dermatol. 1985; 112:291-297.<br />
267. Blackburn P, Projan SJ, Goldberg EB (Applied Microbiology, Inc.) Pharmaceutical bacteriocin<br />
compositions. PCT Int. Appl. WO 93 13,793 (Cl. A61K37/02), 22 Jul 1993, US Appl. 822,433. 17 Jan<br />
1992; 35 pp. (CA)<br />
268. Bjarnason I, Peters TJ, Veall N. A persistent defect in intestinal permeability in coeliac disease<br />
demonstrated by 51Cr-labelled <strong>EDTA</strong> absorption test. Lancet. 1983; 1:323-325.<br />
269. Bjarnason I, Smethurst P, Levi AJ, Peters TJ. Intestinal permeability to 51Cr-<strong>EDTA</strong> in rats with<br />
experimentally induced enteropathy. Gut. 1985; 26:569-585.<br />
270. Bovell-Benjamin AC, Allen LH, Frankel EN, Guinard J-X. Sensory quality and lipid oxidation of<br />
maize porridge as affected by iron amino acid chelates and <strong>EDTA</strong>. J Food Sci. 1999; 64(2):371-376,<br />
Institute of Food Technologists. (CA)<br />
271. Brieger H. The use of chelating agents in occupational medicine. In: Metal-Binding in Medicine by<br />
MJ Seven and LA Johnson, Ed., JB Lippincott Co., Philadelpha. 1960; p. 200-204.<br />
272. Burke LM. Chronic lead poisoning. A case report. West Indian Med. J. 1957; 6(2):105-107. (2922)<br />
273. Burrous SE, Siedler AJ, Eudy WW. Enhancement of ampicillin efficacy by peroral levodopa in rat<br />
pyelonephritis. Life Sci. 11(Pt. II). 1972; 1087-1093.<br />
274. Byczkowska Z, Antczak F (Dzialu Clin. Inst. Med. Pracy, Kodz, Poland). The value of the chelation<br />
test in provoking urinary excretion of lead in the diagnosis of lead intoxication. Medycyna Pracy 14. 1963;<br />
3:211-222. (2506)<br />
275. Cardon BP (to Erly-Fat Livestock Feed Co.). Chelated metals for improving the digestibility of feeds<br />
for ruminants. U.S. 2,960,406, Nov. 15, 1960. (CA55:3872e)<br />
276. Carson RH, Zipkin I, Rubin M. Effect of administration of ethylenediaminetetraacetate (<strong>EDTA</strong>) by<br />
various routes on dental caries in the rat. Arch. Oral Biol. 1961; 5:49-54. (CA56:893a)
277. Carter EB (to Abbott Laboratories). Ferrous chelate compositions for oral administration. U.S.<br />
2,816,060, Dec. 10, 1957. (CA52:4938a)<br />
278. Candela E, Camacho MV, Martinez-Torres C, Perdomo J, Mazzarri G, Acurero G, Layrisse M. Iron<br />
absorption by humans and swine from Fe(III)-<strong>EDTA</strong>. Further studies. J Nutr. 1984; 114:2204-2211.<br />
279. Castellino N, Aloj S. Effects of calcium sodium ethylenediaminetetra-acetate on the kinetics of<br />
distribution and excretion of lead in the rat. Brit. J Indust. Med. 1965; 22:172-180.<br />
280. Chan MS. Some toxicological and physiological studies of ethylenediamine tetraacetic acid in the<br />
albino rat. Dissertation. Univ. Mass. 1956:118 p.<br />
281. Chenoweth MB. <strong>Chelation</strong> as a mechanism of pharmacological action. Pharmacol. Rev. 1956; 8:57-87.<br />
282. Child GP. The inhibition of hematopoietic action of cobalt by ethylenediamine tetraacetic acid<br />
(<strong>EDTA</strong>). Science. 1951; 114:466-467. (CA46:2648i) [A Purina dog chow diet contg. 0.1% Co when fed to<br />
Wistar rats increased the red cell county and the hemoglobin content. Addn. of 5% <strong>EDTA</strong> completely<br />
inhibited the Co effect, while lower concns. (1% and 0.2%) only diminished the Co action.]<br />
283. Ching GWK, Rogers SM, Braithwaite RA, Vale JA. An oral treatment for lead toxicity (Letters).<br />
Postgrad. Med. J. 1991; 67:953.<br />
284. Chisholm Jr. JJ. The use of chelating agents in the treatment of acute and chronic lead intox-ication in<br />
childhood. J Pediat. 1968;73:1-38.<br />
285. Cossack ZT, Van der Hamer CJA. Evaluation of the <strong>EDTA</strong>-washed diet for use in the exper-imental<br />
production of zinc deficiency in human subjects. Int. J Vitam. Nutr. Res. 1987; 57(1):99-102. (CA)<br />
286. Cotter LH. Treatment of cadmium poisoning with edathamil calcium disodium. J Am. Med. Assoc.<br />
1958; 166:735-736. (CA52:10388a) [Cd intoxication was treated successfully with oral edathamil Ca di-Na<br />
(Ca di-Na ethylenediaminetetraacetate). The Ca of the chelating agent was replaced by Cd and excreted in a<br />
nonirritating form through the kidneys.]<br />
287. Clark BJ, Tomich EG. Pharmacological studies on lead E.D.T.A. Brit. Med. J. 1955; 2:831-832.<br />
288. Darwish NM, Kratzer FH. Metabolism of ethylenediaminetetraacetic acid (<strong>EDTA</strong>) by chickens. J Nutr.<br />
1965; 86:187-192. (NA36)<br />
289. Coltart RS, Howard GC, Wraight EP. The effect of hyperthermia and radiation on small bowel<br />
permeability using 51Cr <strong>EDTA</strong> and 14C mannitol in man. Int. J Hyperthermia. 1988; 4:467-477.<br />
290. Cook JD, Monsen ER. Food iron absorption in man. 2. The effect of <strong>EDTA</strong> on absorption of dietary<br />
nonheme iron. Amer. J Clinc. Nutr. 1976; 29(6):614-620. (NA47)<br />
291. Cook JD, Reusser ME. Iron fortification: an update. Am. J Clin. Nutr. 1983; 38:658-659.<br />
292. Figueroa WG. The enhancement of iron excretion in iron-storage disease. In: Metal-Binding in<br />
Medicine by Seven MJ, Johnson LA, Ed., J.B. Lippincott Co., Philadelphia. 1960; p.146-53.<br />
293. Figueroa WG, Adams WS, Davis FW, Bassett SH. A study of the effect of disodium calcium<br />
versenate (Ca<strong>EDTA</strong>) on iron excretion in man. J Lab. Clin. Med. 1955; 46:534-543.
294. Fioretti M (Univ. Padua, Italy). Ethylenediaminetetracetic acid and some salts of pharmaceutical<br />
interest. Ann. Chim. 1963; 53(8-9):1161-1165. (CA60:3998b)<br />
295. Foley WJ, Charles-Dominique P, Julien-Laferriere D. Nitrogen requirements of the didelphid<br />
marsupial Caluromys philander. J Comp. Physiol., B. 2000; 170(5-6):345-350. (CA)<br />
296. Forget P, Sodoyez-Goffaux F, Zappitelli Z. Permeability of the small intestine to (51Cr)<strong>EDTA</strong> in<br />
children with acute gastroenteritis or eczema. J Pediat. Gastroenterol. Nutr. 1985; 4:393-396.<br />
297. Foreman H, Vier M, Magee M. The metabolism of C14-labeled ethylenediaminetetraacetic acid in the<br />
rat. J Biol. Chem. 1953; 203:1045-1053.<br />
298. Forth W, Pfleger K, Rummel W, Seifen E, Richmond SI. Effect of various ligands on the absorption,<br />
distribution, and excretion of iron following oral administration. Arch. Exptl. Pathol. Pharmakol. 1965;<br />
252(3):242-257. (CA64:8801b)<br />
299. Forth W, Rummel W, Pfleger K, Andrews H. The influence of ligands upon retention of iron by<br />
normal and anemic rats after oral application. Naunyn-Schmiedebergs Arch. Pharmakol. Exp. Pathol. 1968;<br />
261(3):225-<br />
300. Fritz JC, Pla GW, Boehne JW. Influence of chelating agents on utilization of calcium, iron, and<br />
manganese by the chick. Poultry Sci. 1970; 49:1386.<br />
301. Elia M, Behrens R, Northrop C, Neale G. Evaluation of mannitol, lactulose and 51Cr-labelled<br />
ethylenediaminetetra-acetate as markers of intestinal permeability in man. Clin. Sci. 1987; 73(2):197-204.<br />
(NA57)<br />
302. Esh GC, Som JM, Bhattacharya H, Bhattacharya S. Stability of vitamins in pharmaceutical<br />
preparations. I. Influence of vehicles in liquid multivitamin oral preparations. Indian J Pharm. 1964;<br />
26:133-136. (CA61:9362h)<br />
303. Evans JL, Ali R. Calcium utilization and feed efficiency in the growing rat as affected by dietary<br />
calcium, buffering capacity, lactose and <strong>EDTA</strong>. J Nutr. 1967; 92(4):417-424. (BA49)<br />
304. Ely CM (to National Distillers Products Corp.). Chick feed containing tri- or tetra-sodium<br />
ethylenediaminetetraacetate. U.S. 2,604,401, July 22, 1952. (CA46:11504b) [Chick growth is accelerated<br />
by the addn. to the diet of 0.15-0.200%, based on the total amt. of food, air-dry basis, of either tri- or tetra-<br />
Na ethylenediaminetetraacetate. The addn. of 0.030 to 0.090% (the optimum amt.) accelerates growth 5%,<br />
although growth continues to be accelerated up to 0.200%.]<br />
305. Engstrom B. Effects of chelating agents on oral uptake and renal deposition and excretion of cadmium.<br />
Environ. Health Perspect. 1984; 54:219-232.<br />
306. Antianemic product. Fr. M484, Mar. 30, 1962, Appl. Aug. 30, 1960; 2 pp. (CA57:16767e)<br />
307. Fairweather-Tait SJ, Wortley GM, Teucher B, Dainty J. Iron absorption from a breakfast cereal:<br />
effects of <strong>EDTA</strong> compounds and ascorbic acid. Int. J Vitam. Nutr. Res. 2001; 71(2):117-122. (CA)<br />
308. Fargeas M-J, Theodorou V, More J, Wal J-M, Foramonti J, Bueno L. Boosted systemic immune and<br />
local responsiveness after intestinal inflammation in orally sensitized guinea pigs. Gastroent. 1995; 109:53-<br />
62.
309. Erdmann WD, Okonek S. Gastrointestinal absorption of the esterase-reactivating substance,<br />
obidoxime, and the possibility of facilitating its absorption. Arch. Toxikol. 1969; 24(2):91-101. (CA70)<br />
310. Dettmar PW, Smith AW. Pharmaceutical compositions containing triclosan or derivatives thereof and<br />
<strong>EDTA</strong> or EGTA. PCT Int. Appl. WO 96 00,569 (Cl. A61K31/195), 11 Jan 1996, GB Appl. 94/13,072, 29<br />
Jun 1994; 27 pp. (CA)<br />
311. Dybing O, Sognen E. Effect of sodium fluoride on the toxicity of red squill. Acta Pharmacol. Toxicol.<br />
1960; 16:242-244. (CA55:6700b)<br />
312. Edwards PJ, Morwood K. Pharmaceutical compositions against gastric disorders containing<br />
bacteriocins. PCT Int. Appl. WO 92 18,143 (Cl. A61K37/02), 29 Oct 1992, GB Appl. 91/8,129, 15 Apr<br />
1991; 15 pp. (CA)<br />
313. Eiichi O, Suzuki S, Fukuda R, Shibata K. The excretion and distribution of radioactive zirconium. I.<br />
Experiments with mice. Gunma J Med. Sci. 1960; 9:203-211. (CA55:19011i)<br />
314. Domingo JL. Developmental toxicity of metal chelating agents. Reproduct. Toxicol. 1998; 12:499-510.<br />
315. Einstman WJ, Klug SL, Patrizio FJ, Rupp G (General Foods Corp.). Iron-fortified soluble coffee<br />
product. Can. 1,032,824 (Cl. 99-81), 13 Jun 1978. Appl. 213,249, 7 Nov 1974, 12 pp. (CA)<br />
316. Durbin PW, Scott KG, Hamilton JC. The distribution of radioisotopes of some heavy metals in the rat.<br />
Univ. of Calif. Publ. in Pharmacol 3. 1957; 1:1-34. (716)<br />
317. Davis PN, Norris LC, Kratzer FH. Iron deficiency studies in chicks using treated isolated soybean<br />
protein diets. J Nutr. 1962; 78(4):445-453. (CA60:4527b)<br />
318. Delgado JN, Lofgren FV, Burlage HM. The relative stability of an oral liquid vitamin preparation.<br />
Drug Standards 26. 1958; 51-56. (CA52:14967a)<br />
319. Davis PN, Norris LC, Kratzer FH. Interference of soybean proteins with the utilization of trace<br />
minerals. J Nutr. 1962; 77:217-223.<br />
320. Fukuda S, Lida H, Hseih YY, Chen W. Toxicological study of DTPA as a drug. VI. Effects of<br />
intravenously injected calcium diethylenetriamine pentaacetic acid (Ca-DTPA), calcium<br />
ethylenediaminetetraacetic acid (Ca-<strong>EDTA</strong>), catechol-3,6-bis(methyleiminodiacetic acid (CBMIDA) and<br />
orally administered zinc DTPA to bone metabolism in beagle dogs. Hoken Butsuri. 1991; 26(2):101-107.<br />
(CA)<br />
321. Furia TE. <strong>EDTA</strong> in foods. A technical review. Food Technol. 1964; 18(12):50-58. (CA62:5796g)<br />
322. Gehres RF, Raymond S. A new chemical approach to the dissolution of urinary calculi. J Urol. 1951;<br />
65:474-483.<br />
323. Gilsanz V, Palacios JM, Rico GG. Treatment of chronic lead poisoning with calcium<br />
ethylenediaminetetraacetate (Ca <strong>EDTA</strong>). Rev. Clin. Espafl. 1955; 57:224-229. (CA50:484e)<br />
324. Gorby CK, Rieders F. The effect of simultaneous oral edathamil calcium disodium and lead acetate on<br />
lead accumulation in tissues of rats. Archiv. Internat. de Pharmacodynamie. 1960; 125:153-160. (896)
325. Greenland AJ, Fuentes Mateos AM. Synergistic antifungal composition for food. PCT Int. Appl. WO<br />
99 02,038 (Cl. A01N63/00, 21 Jan 1999. GB Appl. 97/14,564, 10 Jul 1997; 40 pp. (CA)<br />
326. Grassman E, Kirchgessner M, Hampel G. Cu depletion in rats and chicks with ethylenediamine tetraacetate<br />
and adenine. Arch. Tierernahrung. 1970; 20:537-544. (NA41)<br />
327. Greene DE, Rinehart KE, Stephenson EL. Influence of <strong>EDTA</strong> on blood antibiotic levels following oral<br />
administration of tetracycline compounds. Poultry Sci. 1968; 47(5):1<strong>500</strong>-1504. (CA70)<br />
328. Hall EJ, Batt RM, Brown A. Assessment of canine intestinal permeability, using 51Cr-klabeled<br />
ethylenediaminetetraacetate. Am. J Vet. Res. 1989; 50:2069-2074. (H)<br />
329. Hallberg L. Bioavailability of dietary iron in man. Ann. Rev. Nutr. 1981; 1:123-147.<br />
330. Hallberg L. Iron absorption - new physiological and therapeutic findings. Radio-Isotope Haematol.,<br />
Intern. Symp. I., Freiburg i. B. 1962; 47-64. (CA62:2092d)<br />
331. Hawkins WW, Leonard VG, Maxwell JE, Rastogi KS. A study of the prolonged intake of small<br />
amounts of ethylenediaminetetraacetate on the utilization of low dietary levels of calcium and iron by the<br />
rat. Can. J Biochem. Physiol. 1962; 40;391-395. (CA56:15920b)<br />
332. Halliday RP, Kinnard WJ, Buckley JP. Evaluation of certain hypotensive agents. V. Substituted<br />
polymethylene diamines. J Pharm. Sci. 1964; 53(1):19-23. (CA60:11246h)<br />
333. Hamilton JG, Scott KG. Effect of the calcium salt of Versene on metabolism of plutonium in the rat.<br />
Proc. Soc. Exptl. Biol. Med. 1953; 83:301-305. (CA47:10712h)<br />
334. Heindorff K, Aurich O, Michaelis A, Rieger R. Genetic toxicology of ethylenediaminetetraacetic acid<br />
(<strong>EDTA</strong>). Mutat. Res. 1983; 115(2):149-173. (CA) [A review with ~125 refs. on the genetic toxicol. of<br />
<strong>EDTA</strong>.]<br />
335. Hendershot LC, Forsaith J. Effect of various metal salts of ethylenediamine tetraacetic acid on dental<br />
caries. J Dent. Res. 1958; 17:32-33.<br />
336. Hendershot LC, Mansell RE, Forsaith J. The effect of zinc, nickel and manganese on rat dental caries<br />
and dental enamel metal levels. In: Metal-Binding in Medicine by MJ Seven and LA Johnson, Ed. J.B.<br />
Lippincott Co., Philadelphia. 1960; p.306-311.<br />
337. Henuk YL, Dingle JG. The effect of feeding a balanced diet with or without a micro-mineral premix, a<br />
chelating agent (<strong>EDTA</strong>) and phytase on the performance of laying hens kept in cages. Asian-Australas. J<br />
Anim. Sci. 2000; 13(Suppl.): 195-198. (CA)<br />
338. Herridge CF. A comparative study of the use of ferric chelate in iron-deficiency anaemia. Brit. Med. J.<br />
1958; 2:140-141.<br />
339. Harmon BG, Becker DE, Jensen AH, Norton HW. Effect of di-Na <strong>EDTA</strong> in diets of different iron<br />
levels on utilization of calcium, phosphorus, and iron by rats. J Anim. Sci. 1968; 27(2):418-423. (CA69)<br />
340. Hiers Jr JM, Miller WJ, Blackmon DM. Effect of dietary cadmium and ethylenediamine-tetraacetate<br />
on dry matter digestibility and organ weights in zinc deficient and normal ruminants. J Dairy Sci. 1968;<br />
51:205-209. (NA38)
341. Huo J, Yu B, Lu C. Method for preparing iron enriched nutrient and its products. Faming Zhuanli<br />
Shenqing Gongkai Shuomingshu CN 1,192,334 (Cl. A23L1/30), 9 Sep 1998. appl. 98,100,374, 23 Jan<br />
1998; 5 pp. (CA)<br />
342. Hodgkinson R. A comparative study of iron absorption and utilization following ferrous sulphate and<br />
sodium ironedetate ("Sytron??"). Med. J Aust. 1961; 1:809-811.<br />
343. Horiguchi S, Iwataki N., Nagao Y, Hasimoto K, Watanabe S, Oda K. A case of lead poisoning<br />
complicated with intestinal adhesion, with special reference to Ca-<strong>EDTA</strong> therapy. Nippon Geka Hokan.<br />
1957; 26:579-585. (1804)<br />
344. Hurrell RE. Preventing iron deficiency through food fortification. Nutr. Rev.<br />
345. Hyde JAJ, Riddington DW, Hutton P, Wilson IC, Boivin CM, Nash G, Graham TR. Prevention of<br />
remote organ injury in cardiopulmonary bypass: the impact of flow generation technique. Artif. Organs.<br />
1997; 21:825-829.<br />
346. Jenkins RT, Jones DB, Goodacre, RL, Collins SM, Coates G, Hunt RH, Bienenstock J. Reversibility<br />
of increased intestinal permeability to 51Cr-<strong>EDTA</strong> in patients with gastrointestinal inflammatory diseases.<br />
Am. J Gastroenterol. 1987; 82:1159-1164.<br />
347. International Nutritional Anemia Consultative Group, Washington, D.C. Iron <strong>EDTA</strong> for food<br />
fortification. ILSI-Nutrition Foundation. 1993.<br />
348. Igarashi K, Sasaki A, Yoda Y, Inage H, Nakanishi Y, Yanagiya T, Hirunuma R, Enomoto S, Kimura S.<br />
Effect of sodium iron ethylenediaminetetraacetic acid on the absorption of various trace elements in anemic<br />
rats. RIKEN Rev. 2001; 35:50-54. (CA)<br />
349. Jacobsen C, Hartvigsen K, Thomsen MK, Hansen LF, Lund P, Skibsted LH, Holmer G, Adler-Nissen<br />
J, Meyer AS. Lipid oxidation in fish oil enriched mayonnaise: calcium disodium<br />
ethylenediaminetetraacetate, but not gallic acid, strongly inhibited oxidative deterioration. J Agric. Food<br />
Chem. 2001; 49(2):1009-1019. (CA)<br />
350. Janner M, Muehlbauer RC, Fleisch H. Sodium <strong>EDTA</strong> enhances intestinal absorption of two<br />
bisphosphonates. Calcif. Tissue Int. 1991; 49(4):280-283. (CA)<br />
351. Jenkins RT, Rooney PJ, Jones DB, Bienenstock J, Goodacre RL. Increased intestinal permeability in<br />
patients with rheumatoid arthritis: a side-effect of oral nonsteroidal anti-inflammatory drug therapy? Brit. J<br />
Rheumatol. 1987; 26:103-107.<br />
352. Kanyuka AI. Effect of unithiol and calcium disodium <strong>EDTA</strong> on the morphological profile of the blood.<br />
Nauk. Pr.-Ukr. Sil's'kogospod. Akad. 1976; 156(2):64-65. (CA)<br />
353. Karunajeewa H. The effect of cockle-shell grit, dietary level of calcium and <strong>EDTA</strong> on eggshell quality<br />
and laying performance of crossbred hens. Aust. J Exp. Agric. Anim. Husb. 1978; 18(94):667-674. (CA)<br />
354. Kearney DR, Kirksey Jr. ST. (The Proctor & Gamble Company, USA). Aminopolycarboxylate- and<br />
polyphosphate-containing beverage products having superior vitamin stability. PCT Int. Appl. WO 00<br />
53,036 (Cl. A23L2/02), 14 Sep 2000. US Appl. PV123,271, 8 Mar 1999; 20 pp. (CA)<br />
355. Karunajeewa H. Effects of rearing regime, a chelating agent and the source of supplemental calcium<br />
and protein in the laying diet on egg shell thickness and performance of crossbred layers. Aust. J Exp.<br />
Agric. Anim. Husb. 1977; 17(89):934-943. (CA)
356. Kim II. K, Benevenga NJ, Grummer RH. Estimation of the fraction of the lactose in a high lactose diet<br />
available for fermentation in the cecum and colon of the rat. J Nutr. 1978; 108(1):79-89. (CA)<br />
357. Kim KY, Bom HS, Oh CS, Lee HC, Park RD, Kim HK, Choe KH, Kim YH, Chae KM, Kim JY.<br />
Genetic toxicity of chitosan and <strong>EDTA</strong> in mice. Kichin, Kitosan Kenkyu. 1996; 2(2):122-123. (CA)<br />
358. Kim SC, Kim YH. Effect of <strong>EDTA</strong> on dental growth in rabbits. J Korean Dent. Acad. Ass. 1970;<br />
8(5):433-438. (CA74)<br />
359. Kealy RD, Greene DE, Waldroup PW, Stephenson EL. Absorption and distribution of<br />
ethylenediaminetetraacetic acid (<strong>EDTA</strong>) ingested by the chick. Poultry Sci. 1969; 48:94-99. (NA40)<br />
360. Kim SW, Kawashima R, Uesaka S. Importance of trace elements in farm animal feeding. XXXIX.<br />
Action mechanism of effects of amino acid and protein on trace element toxicity in cellulose digestion by<br />
rumen bacteria. Kyoto Daigaku Shokuryo Kagaku Kenkyusho Hokoku.m 1969; 32:17-23. (CA75)<br />
361. Kratzer FH, Starcher B. Quantitative relation of <strong>EDTA</strong> to availability of zinc for turkey poults. Proc.<br />
Soc. Exp. Biol. Med. 1963; 113:424-426. (NA34)<br />
362. Kristoffersen J, Lõkken P. A comparison between phenol red and 51Cr-<strong>EDTA</strong> as reference substances<br />
in rats by a test meal technique. Acta Pharmacol. Toxicol. 1971; 30:97-103.<br />
363. Krum JK, Fellers CR. Clarification of wine by a sequestering agent. Food Technol. 1952; 6;103-106.<br />
364. Krum J. Toxicological and food usage studies of ethylenediaminetetraacetic acid. Dissertation. Univ.<br />
Mass. 1948: 44 p.<br />
365. Kimmel CA. Fetal gonad dysgenesis following <strong>EDTA</strong> administration. Teratology. 1975; 11:26A.<br />
366. Kimmel CA, Sloan CS. Studies on the mechanism of <strong>EDTA</strong> teratogenesis. Teratology. 1975: 12:330-<br />
331.<br />
367. Knasmüller S, Szakmary A, Wottaw A. Investigations on the use of <strong>EDTA</strong>-permeabilized E. coli cells<br />
in liquid suspension and animal-mediated genotoxicity assays. Mutat. Res. 1989; 216:189-196.<br />
368. Kurilov NV, Podshibyakin AE. Utilization and digestibility of pectin-, ethylenediamine-tetraacetic<br />
acid - and formaldehyde-treated casein fed to sheep. Byull. Vses. Nauchno-Issled. Inst. Fiziol., Biokhim.<br />
Pitan. S-kh. Zhivotn. 1983; 17(1): 28-30. (CA)<br />
369. LaChance LE. The effect of chelation and x-rays on fecundity and induced dominant lethals in<br />
Habrobracon (Bracon). Radiation Res. 1959; 11:218-228. (CA54:664a)<br />
370. Kovacs T, Jun L, Schmelczer M, Wagner L, Davin J-C, Nagy J. Do intestinal hyperpermeability and<br />
the related food antigens play a role in the progression of IgA nepropathy? 1. Study of intestinal<br />
permeability. Am. J Nephrol. 1996; 16;<strong>500</strong>-505.<br />
371. Kratzer FH, Allred JB, Davis PN, Marshall BJ, Vohra P. The effect of autoclaving soybean protein<br />
and the addition of ethylenediaminetetraacetic acid on the biological availability of dietary zinc for turkey<br />
poults. J Nutr. 1959; 68:313-322.<br />
372. Lange J, Pickardt E, Weinig E. Diagnosis and therapy of lead injury by complex formers. Arztliche<br />
Wochenschrift. 1959; 14:105-111. (2034)
373. Leclercq-Foucart J, Forget P, Sodoyez-Goffaux F, Zappitelli A. Intestinal permeability to<br />
(51Cr)<strong>EDTA</strong> in children with cystic fibrosis. J Pediat. Gastroenterol. Nutr. 1986; 5:384-387.<br />
374. Läpinleimu K, Wegelius R. The intestinal absorption of iron administered orally. Therapeutic effect in<br />
infants and children with hypochromic anemia. Antibiotic Med. & Clin. Therapy. 1959; 6:151-155.<br />
(CA43:13391f)<br />
375. Larsen BA, Bidwell RGS, Hawkins WW. The effect of ingestion of disodium ethylenediaminetetraacetate<br />
on the absorption and metabolism of radioactive iron by the rat. Can. J Biochem. and Physiol.<br />
1960; 38:51-55. (CA54:4923i)<br />
376. Larsen BA, Hawkins WW, Leonard VG, Armstrong JE. The effect of the prolonged intake of<br />
ethylenediaminetetraacetate on the utilization of calcium and iron by the rat. Can. J Biochem. and Physiol.<br />
1960; 38:813-817. (CA54:23067b)<br />
377. Larson RH, Zipkin I, Rubin M. Effect of administration of <strong>EDTA</strong> by various routes on dental caries in<br />
the rat. Possible role of coprophagy. Arch. Oral. Biol. 1961; 5:49-54.<br />
378. Leighton MJ, Bhabuta A, Hill R. Comparison of the retention in chicks and mice of 59Fe given orally<br />
as chloride, ethylene diamine tetra-acetate or nitrilotriacetate and in chicks given diets composed of<br />
conventional ingredients or semi-purified nutrients. Res. Vet. Sci. 1990; 49:138-143.<br />
379. Layrisse M, Garcia-Casal MN, Solano L, Baron MA, Arguello F, Llovera D, Ramirez J, Leets I,<br />
Tropper E. Iron bioavailability in humans from breakfasts enriched with iron bis-glycine chelate, phytates<br />
and polyphenols. J Nutr. 2000; 130(9):2195-1999. (CA)<br />
380. Layrisse M, Martinez-Torres C. Fe(III) <strong>EDTA</strong> complex as iron fortification. Amer. J Clin. Nutr. 1977;<br />
30(7):1166-1174. (NA48)<br />
381. Lea P, Coke M, Morwood K, Smith AW. (Smithkline Beecham PLC) Pharmaceutical composition for<br />
the treatment of gastritis. PCT Int. Appl. WO 92 18,111 (Cl. A61K31/045), 29 Oct 1992. GB Appl.<br />
91/8,080, 15 Apr 1991; 14 pp. (CA)<br />
382. Lease, JG, Barnett BD, Lease EJ, Turk DE. The biological unavailability to the chick of zinc in a<br />
sesame meal ration. J Nutr. 1960; 72:66-70.<br />
383. Lengemann FW, Wasserman RH, Comar CL. Enhancement of radiocalcium and radiostrontium<br />
absorption by lactose in the rat. J Nutr. 1959; 68:443-456. (CA53:22323b)<br />
384. Likuski HJA, Forbes RM. Effect of phytic acid on the availability of zinc in amino acid and casein<br />
diets fed to chicks. J Nutr. 1964; 84:145-148. (NA35)<br />
385. Loercher K, Koeppe P, Akkilie M. Influence of <strong>EDTA</strong> on retention and biological half-life of<br />
manganese-54 and zinc-65 in chickens. Trace Elem. Metab. Anim., Proc. WAAP/IBP Int. Symp. 1969 (Pub.<br />
1970); 259-263. (CA75)<br />
386. Lõkken P, Sõgnen E. 51Cr-<strong>EDTA</strong> as a reference substance in research on gastrointestinal functions.<br />
Gen. Pharmacol. 1967; 25(Suppl. 4):39.<br />
387. Loren K. Dr. Garry F. Gordon world's leading medical advocate of oral chelation. Life flow one the<br />
solution for heart disease. 21 p. computer printout.
388. Makashev KK, Akhmedova AS. The effect of ethylenediaminetetraacetate (<strong>EDTA</strong>) and cortisone on<br />
the distribution of phosphorus and calcium in organs and tissues and their excretion from the system after<br />
lead intoxication. Trudy Instituta Kraevoi Patologii, Akademiya Nauk Kazakhskoi SSR. 1962; 10:190-197.<br />
(1009)<br />
389. Makeeva LG, Pavlovskaya NA, Orlyanskaya RL. The distribution of thorium in rat liver depending on<br />
the route of administration and chemical nature of the compounds introduced. Med. Radiol. 1968; 13(9):50-<br />
63. (CA70)<br />
390. Maestri DM, Labuckas DO, Guzman CA. Chemical and physical characteristics of a soybean<br />
beverage with improved flavor by addition of ethylenediaminetetraacetic acid. Grasas Aceites (Sevilla).<br />
2000; 51(5):316-319. (CA)<br />
391. Maxton DG, Bjarnason I, Reynolds AP, Catt SD, Peters TJ, Menzies IS. Lactulose, 51Cr-labeled<br />
ethylenediaminetetraacetate, L-rhamnose and polyethyleneglycol 400 (corrected) as probe markers for<br />
assessment in vivo of human intestinal permeability. Clin. Sci. 1986; 71:71-80.<br />
392. McCall JT, McLennan KG, Goldstein NP, Randall RV. Copper and zinc homeostasis during chelation<br />
therapy. Trace Subst. Environ. Health. 1969; 2:127-140.<br />
393. McLean AEM. Phenergan and versene in dietary liver necrosis. Nature. 1960; 185:191-192.<br />
(CA54:16652b) [The decline in O uptake of liver slices of weanling rats fed a necrogenic diet was<br />
prevented by the addn. of 10-4M Phenergan or 10-3M Versene. The addn. of Phenergan to the necrogenic<br />
diet delayed the onset of massive liver necrosis.]<br />
394. Martinez-Torres C, Romano EL, Renzi M, Layrisse M. Fe(III)-<strong>EDTA</strong> complex as iron fortification.<br />
Further studies. Amer. J Clin. Nutr. 1979; 32(4):809-816. (NA50)<br />
395. Masuda K. Studies on removal of radioactive contamination in body. 2. Removal of Ca45 and Sr90 by<br />
oral administration of ethylenediaminetetraacetic acid in rat. J Nara Med. Assoc. 1963; 14:138-142.<br />
(NA34)<br />
396. Mathers JC, Smith H, Carter S. Dose-response effects of raw potato starch on small-intestinal escape,<br />
large-bowel fermentation and gut transit time in the rat. Brit. J Nutr. 1997; 78:1015-1029.<br />
397. Miller JK, Byrne WF. Absorption, excretion, and tissue distribution of orally and intravenously<br />
administered radiocerium as affected by <strong>EDTA</strong>. J Dairy Sci. 1970; 53:171-175. (NA40)<br />
398. Miller WJ, Powell GW, Blackmon DM, Gentry RP. Zinc and dry matter content of tissues and feces of<br />
zinc-deficient and normal ruminants fed ethylenediaminetetraacetate and cadmium. J Dairy Sci. 1968;<br />
51:82-89. (NA38)<br />
399. McWard GW. Effects of phytic acid and ethylenediaminetetraacetic acid (<strong>EDTA</strong>) on the chick's<br />
requirement for magnesium. Poultry Sci. 1969; 48:791-794. (NA40)<br />
400. Milos M, Contrea A, Crista N, Rosu Maria. Effect of chelation of trace minerals (manganese, copper,<br />
and cobalt) with <strong>EDTA</strong> on oxygen consumption in liver tissue and the activity of some enzymes of chicken<br />
serum. Lucr. Stiint., Inst. Agron. Timisoara, Ser. Zooteh. 1970; 13:59-66. (CA80)<br />
401. Mendoza C, Viteri FE, Lonnerdal B, Raboy V, Young KA, Brown KH. Absorption of iron from<br />
unmodified maize and genetically altered low-phytate maize fortified with ferrous sulfate or sodium iron<br />
<strong>EDTA</strong>. Am. J Clin. Nutr. 2001; 73:80-85.
402. Mittler TE. Ascorbic acid and other chelating agents in the trace-mineral nutrition of the aphid Myzus<br />
persicae on artificial diets. Entomol. Exp. Appl. 1976; 20(1):81-98. (CA)<br />
403. Merville R, Dequidt J, Corteel ML, Fontaine G. Electrophoretic study of the serum proteins in chronic<br />
occupational lead poisoning. Lille Med. 1958; 3:139-143. CA55:15725b)<br />
404. Sognen E. Reduction of the toxic effect of certain orally administered drugs by co-administration of<br />
calcium binding substances. Proc. European Soc. Study Drug Toxicity. 1964; 4:190-197. (CA65:4454g)<br />
405. Sognen E. Calcium-binding substances and intestinal absorption. A survey of literature and own<br />
investigations. Acta Pharmacol. Toxicol. 1964; Suppl 1: 31 pp. (CA62:6899d)<br />
406. Mamduh S, Lowry DC, Kratzer FH, Norris LC. Effect of NTA and <strong>EDTA</strong> on calcium metabolism of<br />
chickens and Coturnix. J Nutr. 1978; 108(4):719-730. (CA)<br />
407. Solomons NW, Jacob RA, Pineda O, Viteri FE. Studies on the bioavailability of zinc in man. Effects<br />
of the Guatemalan rural diet and of the iron-fortifying agent, NaFe<strong>EDTA</strong>. J Nutr. 1979; 109(9):1519-1528.<br />
(NA50)<br />
408. Skorkowska-Zieleniewska J, Bartnik J, Mentel M. Preliminary studies on the effect of versenates on<br />
the organism in the light of views on possibilities of the use of these compounds in the food industry.<br />
Przem. spoz. 1969; 23:237-240. (NA40)<br />
409. Stantschew S. Prevention of chronic saturnism by oral use of calcium-sodium-<strong>EDTA</strong>. Zeitschrift fur<br />
die Gesamte Hygiene und Ihre Grenzgebiete. 1964; 10:180-186. (2818)<br />
410. Stevens E, Rosoff B, Weiner W, Spencer H. Metabolism of the chelating agent diethylenetriamine<br />
pentaacetic acid (C14DTPA) in man. Proc. Soc. Exptl. Biol. Med. 1962; 111:235-238.<br />
411. Sullivan TJ. Effect of manganese edetate (ethylenediaminetetraacetate) on blood formation in rats.<br />
Nature. 1960; 186:87. (CA54:17592e) [A severe but reversible Fe-deficiency anemia was produced in<br />
immature but not in adult rats by feeding a diet contg. 4% Mn edetate.]<br />
412. Tada O, Sawano T, Nakaoki K. Effect of calcium <strong>EDTA</strong> administration on the heavy metal content of<br />
liver, kidney, and spleen. Rodo Kagaku. 1964; 40(6):252-258. (CA63:16996f)<br />
413. Suso FA, Edwards Jr. HM. Ethylenediaminetetraacetic acid and zinc-65 binding by intestinal digesta,<br />
intestinal mucosa, and blood plasma. Proc. Soc. Exp. Biol. Med. 1971; 138(1):157-162. (CA76)<br />
414. Taylor DM. The absorption of cobalt from the gastrointestinal tract of the rat. Phys. Med. Biol. 1962;<br />
6:445-451. (CA56:12137e)<br />
415. Taylor SM, Mallon TR, Blanchflower WJ, Kennedy DG, Green WP. Effects of diet on plasma<br />
concentrations of oral anthelmintics for cattle and sheep. Vet. Rec. 1992; 130:264-268.<br />
416. Teahon K, Somasundaram S, Smith T, Menzies I, Bjarnason I. Assessing the site of increased<br />
intestinal permeability in coeliac and inflammatory bowel disease. Gut. 1996; 38:864-869.<br />
417. Thomas PS, Ashton C. An oral treatment for lead toxicity. Postgrad Med. J. 1991; 67:63-65.<br />
418. Thomas RO, Litovitz TA, Geschickter CF. Alterations in dynamics of calcium metabolism by<br />
intraintestinal calcium reservoirs. Am. J Physiol. 1954; 176:381-387.
419. Troncon LE de A, Pires CR, Kraus OA, Iazigi N. Estudo de permeabilidade intestinal pelo teste do 51-<br />
Cr<strong>EDTA</strong>: utilidade clinica na deteccao de alteracoes estruturais do epitelio do intestino delgado. Arq.<br />
Gastroenterol. 1996; 33:66-73.<br />
420. Turck D, Ythier H, Maquet E, Deveaux M, Marchandise X, Farriaux JP, Fontaine G. Intestinal<br />
permeability to (51Cr)<strong>EDTA</strong> in children with Crohn's disease and celiac disease. J Pediat. Gastroenterol.<br />
Nutr. 1987; 6:535-537.<br />
421. Valledor T, Borbolla L, Villa Campos J, Garcia Palacio A, Garcia Otero A. Lead poisoning in infants:<br />
Recent advances in the treatment; 8 cases in 2 families. Revista Colombiana de Pediatria Puericultura.<br />
1956; 16:173-194. (2917)<br />
422. Verma M, Ganguly NK, Majumdar S, Walia BNS. 51-Cr-labelled ethylenediaminetetraacetic acid and<br />
D-xylose absorption test in Escherichia coli enterotoxin-induced diarrhoea in mice. Scand. J Gastroenterol.<br />
1995; 30:886-891.<br />
423. Vinas-Salas J, Biendicho-Palau P, Pinol-Felis C, Miguelsanz-Garcia S, Perez-Holanda S. Calcium<br />
inhibits colon carcinogenesis in an experimental model in the rat. Eur. J Cancer. 1998; 34(12):1941-1945.<br />
(CA)<br />
424. Valverde A, Murillo A. Endogenous excretion of calcium: effects of sodium oxalate, sodium citrate,<br />
sodium lactate and <strong>EDTA</strong>. Ars. Pharm. 1978; 19(4): 353-360. (CA)<br />
425. Viteri FE, Alvarez E, Batres R, Torun B, Pineda O, Mejia LA, Sylvi J. Fortification of sugar with iron<br />
sodium ethylenediaminetetraacetate (FeNa<strong>EDTA</strong>) improves iron status in semirural Guatemalan<br />
populations. Am. J Clin. Nutr. 1995; 61:1153-1163.<br />
426. Varela G, Murillo A. Influence of sodium oxalate and <strong>EDTA</strong> on the digestibility and endogenous fecal<br />
elimination of calcium in rats. An. Bromatol. 1967; 19(1):91-112. (CA67)<br />
427. Varela G, Sanchez FS. Pharmacodynamics of sodium versene. I. Toxicity and action on smooth<br />
muscle. Arch. inst. farmacol. exptl. 1952; 4:5-11. (CA47:6554b)<br />
428. Viteri FE, Garcia-Ibanez R, Torun B. Sodium iron <strong>EDTA</strong> as an iron fortification compound in Central<br />
America. Am. J Clin. Nutr. 1978; 31(6):961-971.<br />
429. Vohra P, Gonzales N. Effect of <strong>EDTA</strong> on the preferential intestinal absorption of zinc than manganese<br />
in turkey poults. Poultry Sci. 1969; 48(4):1509-1510. (CA72)<br />
430. Vasiljevic S, Kalic-Filipovic D, Andelovski A. Experiences in oral and parenteral application of<br />
CaNa2<strong>EDTA</strong>. Arh. Hig. Rada. Toksikol. 1969; 20(4):Suppl:113-121.<br />
431. Vergara P, Ferrando C, Jimenez M, Fernandez E, Gonalons E. Factor determining gastrointestinal<br />
transit time of several markers in the domestic fowl. Quart. J Exp. Physiol. 1989; 74:867-874.<br />
432. Vohra P, Gottfredson GD, Kratzer FH. The effects of high levels of dietary <strong>EDTA</strong>, zinc or copper on<br />
the mineral contents of some tissue of turkey poults. Poultry Sci. 1968; 47:1334-1343. (NA39)<br />
433. Vozar L, Simko V. The blood picture of rats given Komplexon 3 (disodium<br />
ethylenediaminetetraacetate). Biologia. 1959; 14:611-617. (CA54:23065d)<br />
434. Vohra P, Davis MJ, Craig RM. The improvement of hatchability of Coturnix (Japanese Quail) eggs by<br />
<strong>EDTA</strong>. Poultry Sci. 1970; 49:780-783.
435. Vohra P, Kratzer FH. Influence of various chelating agents on the availability of zinc. J Nutr. 1964;<br />
82:249-256. (NA34)<br />
436. Vozar L. Iron balance and level in the organism after the administration of disodium salt of<br />
ethylenediaminetetraacetic acid. Ceskoslov. gastroenterol. vyziva. 1959; 13:261-269. (CA54:10158c)<br />
437. Vohra P, Kratzer FH. Influence of various phosphates and other complexing agents on the availability<br />
of zinc for turkey poults. J Nutr. 1966; 89(1):106-112. (CA65: 14177d)<br />
438. Vohra P, Kratzer FH. Zinc, copper, and manganese toxicities in turkey poults and their alleviation by<br />
<strong>EDTA</strong>. Poultry Sci. 1968; 47(3):699-704. (CA69)<br />
439. Waldroup PW, Bowen TE, Morrison HL, Hull SJ, Tollett VE. The influence of <strong>EDTA</strong> on performance<br />
of chicks fed corn-soybean meal diets with and without trace mineral supplementation. Poultry Sci. 1968;<br />
47:956-960. (NA39)<br />
440. Whittaker P, Vanderveen JE, Dinovi MJ, Kuznesof PM, Dunkel VC. Toxicological profile, current use,<br />
and regulatory issues on <strong>EDTA</strong> compounds for assessing use of sodium iron <strong>EDTA</strong> for food fortification.<br />
Regulatory Toxicol. Pharmacol. 1993; 18:419-427.<br />
441. Weerden EJ Van. Reduced availability of iron in diets for fattening calves. Landbouwkundig<br />
Tijdschrift. 1973; 85(11):388-394. (NA44)<br />
442. Westrom BR, Wang Q, Pantzar N, Jeppsson B, Karlsson B. Intestinal passage of 51-Cr-<strong>EDTA</strong> and<br />
ovalbumin in the rat with intra-abdominal sepsis. Adv. Exp. Med. Biol. 1995; 371B:887-889.<br />
443. White HH. Diagnosis and treatment of lead poisoning. World Neurology. 1960; 1:137-145. (2218)<br />
444. Willoughby RPN, Harris KA, Carson MW, Martin CM, Troster M, DeRose G, Jamieson WG, and<br />
Potter RF. Intestinal mucosal permeability to 51-Cr-ethylenediaminetetraacetic acid is increased after<br />
bilateral lower extremity ischemia-reperfusion in the rat. Surgery. 1996; 120:547-553.<br />
445. Whittaker P, Vanderveen JE. Effect of <strong>EDTA</strong> on the bioavailability to rats of fortification iron used in<br />
Egyptian balady bread. British J Nutr. 1990; 63(3):587-595. (NA60)<br />
446. Wilson BB, Wortharm JS. (Allied Chemical Corp.) Urea-containing ruminant feed comprising<br />
inhibitors of urease enzymes. U.S. 3,644,642 (Cl. 424-319; A61k), 22 Feb 1972. 1969; Appl. 816,107, 3 pp.<br />
(CA76)<br />
447. Yip R. The challenge of controlling iron deficiency: sweet nets from Guatemala. Am. J Clin. Nutr.<br />
1995; 61:1164-1165.<br />
448. Wittgens H, Heider. Inflammation of the optic nerves and lead poisoning. Arztliche Dienst DB. 1958;<br />
19:71-73. (1977)<br />
449. Woods WR, Smith KJ. Control of bloat in ruminants. U.S. 3,317,378 (Cl. 167-53), May 2, 1967. Appl.<br />
June 18, 1962; 3 pp. (CA67) [The administration of a chelating agent such as <strong>EDTA</strong> prevents bloat in<br />
ruminants by reducing free Mg and Ca ions in the rumen. The chelating agent should be given orally at<br />
least once every 24 hours. The dose depends on species and age of the animals.]<br />
450. Wu CL. Zinc and manganese requirements of Tsai Ya ducklings and factors affecting requirements.<br />
Chung-hua Nung Hsueh Hui Pao. 1982; 119:75-85. (CA)
451. Zahorski W, Myslak Z. Use of Ca-<strong>EDTA</strong> in the organized action against plumbism in industry. XII<br />
Internatl. Cong. Occup. Health, Helsinki, Finland. 1957; Vol. III, pp. 242-243. (1881)<br />
452. Zimmer FE. Lead poisoning in scrap-metal workers. J Amer. Med. Assoc. 1961; 175:238-240. (2356)<br />
453. Zipkin I. Caries-potentiating effect of ethylenediaminetetraacetic acid in the rat. Proc. Soc. Exptl. Biol.<br />
Med. 1953; 82:80-83. (CA47:4972f)<br />
454. Zipkin I, Larson RH. Caries potentiating effect of Na <strong>EDTA</strong>, Ca <strong>EDTA</strong>, and Mg <strong>EDTA</strong> in the rat. J<br />
Dent. Res. 1959; 38:1240.<br />
455. Zipkin I. Further studies on in vivo decalcifying agents. Versene (ethylene diamine tetra acetic acid),<br />
various polycarboxylic acids and various polyphosphates at pH 6.5. J Dent. Res. 1951; 30:484.<br />
456. Mochmann H, Zwierzchowski J, Hering L, Molenda J, Ocklitz HW, Bocianowski M, Austenat L,<br />
Walachowski W, Janas Z. The protective effect of an <strong>EDTA</strong>-sodium-extract-vaccine obtained from swinepathogenic<br />
E. coli in a field trial. 1. Communication: Direct and indirect immunization of suckling piglets.<br />
Zentralbl. Bakteriol. A. 1980; 247;192-207.<br />
457. Mochmann H, Zwierzchowski J, Hering L, Molenda J, Ocklitz HW, Bocianowski M, Austenat L,<br />
Walachowski W, Janas Z. The protective effect of an <strong>EDTA</strong>-sodium-extract-vaccine obtained from swinepathogenic<br />
E. coli in a field trial. 2. Communication. Immunization of weanling piglets. Zentralbl.<br />
Bakteriol. A. 1980; 247:208-220.<br />
458. Mochmann H, Zwierzchowski J, Hering L, Molenda J, Ocklitz HW, Bocianowski M, Austenat L,<br />
Walachowski W, Janas Z. Preliminary results of an antiepizootic field test using <strong>EDTA</strong>-Na extract vaccine<br />
from Escherichia coli strains pathogenic to swine in swine production industrial units. Arch. Exp.<br />
Veterinarmed. 1979; 33:489-494.<br />
459. Miyao N, Hayashi M. Strontium metabolism following strontium-calcium discrimination in domestic<br />
animals. V. Effects of various salts and whole-body cobalt-60 gamma irradiation on the strontium-calcium<br />
discrimination in the goat and fowl. Nippon Juigaku Zasshi. 1961; 23:181-189. (CA56:14785i)<br />
460. Murillo A, Campos MS, Varela G. Factors affecting digestibility, absorption and retention of calcium.<br />
Effect of oxalate, ethylenediamine tetraacetic acid (disodium salt), nitrilotriacetic acid, lysine and protein<br />
quality. Revista Espanola de Fisiologia. 1972; 28(2):115-123. (NA43)<br />
461. Morello MJ, Franz SL. <strong>EDTA</strong> supplementation of L-ascorbic acid-containing beverages for increased<br />
stability of color and clarity. Eur. Pat. Appl. EP 1,121,868 (Cl. A23L2/68) 8 Aug 2001. US Appl. 495,768,<br />
1 Feb 2000; 8 pp. (CA)<br />
462. Morris AJ, Howden CW, Robertson C, Duncan A, Torley H, Sturrock RD, Russell RI. Increased<br />
intestinal permeability in ankylosing spondylitis - primary lesion or drug effect? Gut. 1991; 32:147-1472.<br />
463. Moustfa HH, Collins EB. Effects of selected food additives on growth of Pseudomonas fragi. J Dairy<br />
Sci. 1968; 52:335-340.<br />
464. Muralidhara NK. Assessment of in vivo mutagenic potency of ethylenediaminetetraacetic acid in<br />
albino mice. Food Chem. Toxicol. 1991; 29(12):845-849. (CA)<br />
465. Naylor GJ. Treatment of pre-menstrual syndrome. U.S. US 4,414,212 (Cl. 424-247; A61K31/54) 08<br />
Nov 1983. Appl. 354,065, 02 Mar 1982; 3 pp. (CA)
466. Nielsen JB, Andersen O, Svendsen P. Chelators and cadmium toxicology after oral exposure. Plzen<br />
Lek Sborn. 1985; Suppl. 49:37-42.<br />
467. Nigrovic V, Catsch A. The treatment of acute iron poisoning in animals. Arch. Exptl. Pathol.<br />
Pharmakol. 1965; 251(2):225-232. (CA63:13918g)<br />
468. O'Dell BL, Yohe JM, Savage JE. Zinc availability in the chick as affected by phytate, calcium and<br />
ethylenediaminetetraacetate. Poultry Sci. 1964; 43:415-419. (NA34)<br />
469. Oman H, Blomquist L, Henriksson AE.K., Johansson S.G.O. Comparison of polysucrose 1<strong>500</strong>0, 15-<br />
Cr-labelled ethylenediaminetetraacetic acid, and 14-C-mannitol as markers of intestinal permeability in<br />
man. Scand. J Gastroenterol. 1995; 30:1172-1177.<br />
470. Omah H, Henriksson AEK, Johansson SGO, Blomquist L. Detection of naproxen-induced intestinal<br />
permeability change may be facilitated by adding a standardized mea but not by forming marker ratios.<br />
Scand. J Gastroenterol. 1996; 31:1182-1188.<br />
471. O'Morain CA, Abelow AC, Chervu LR, Fleischner GM, and Das, KM. Chromium 51ethylenediaminetetraacetate<br />
test: a useful test in the assessment of inflammatory bowel disease. J Lb. Clin.<br />
Med. 1986; 108:430-435.<br />
472. Onning G, Wang Q, Westrom BR, Asp NG, Karlsson BW. Influence of oat saponins on intestinal<br />
permeability in vitro and in vivo in the rat. Brit. J Nutr. 1996; 76;141-151.<br />
473. Orita J. Experimental studies on the effect of monocalcium disodium ethylenediaminetetraacetate<br />
upon lead poisoning. Kokumin Eise. 1956; 25:22-55. (CA51:13185i)<br />
474. Osani H, Motomura H, Makihata M. Continuous oral administration of calcium <strong>EDTA</strong>. Rodo Kagaku.<br />
1964; 40(3):113-120. (CA63:16996e)<br />
475. Owen AA, Peo Jr. ER, Cunningham PJ, Moser BD. Chelated trace minerals for G-F swine. J of<br />
Animal Sci. 1973; 37(1):95-103. (NA44)<br />
476. Paruelle JL, Toullec R, Patureau-Mirand P, Mathieu CM. Utilisation of protein by fattening<br />
preruminant calves. 2. Utilisation of fish proteins and the effect of an iron-chelating agent. Annales de<br />
Zootechnie. 1974; 23(4):519-535. (NA46)<br />
477. Patrick H. Relation of hydrobiotite and complexing agents to mineral metabolism. Proc. W.Va. Acad.<br />
Sci. 1968; 40:77-80. (CA70)<br />
478. Pavlovskaya NA, Provotorov AV, Makeeva LG. Resorption of thorium from the gastrointestinal tract<br />
by the blood and its accumulation in organs and tissues of rats. Gig. Sanit. 1971; 36(5):47-50. (CA75)<br />
479. Perry Jr. HM, Camel GH. Effects of calcium disodium ethylenediaminetetraacetate on plasma<br />
cholesterol and urinary Zn in man. Metal-Bind Med., Proc. Symposiu, Philadelphia 1959. 1960; 209-215.<br />
(CA54:18787i)<br />
480. Podshibyakin AE, Kurilov NV. Effects of dietary protein coating on the nitrogen flow from the<br />
forestomach into the abomasum of sheep. Byull. Vses. Nauchno-Issled. Inst. Fiziol. Biokhim. Pitan. S-kh.<br />
Zhivotn. 1983; 16(4):30-33. (CA)<br />
481. Peters HA. <strong>Chelation</strong> therapy in acute, chronic and mixed porphyria. In: Metal-Binding in Medicine<br />
by MJ Seven and LA Johnson, Ed. J.B. Lippincott Co., Phila. 1960; p.190-199.
482. Powell GW. Effects of dietary <strong>EDTA</strong> and cadmium on absorption, excretion, and retention of orally<br />
administered 65Zn in various tissues of zinc-deficient and normal goats and calves. Dissertation Absts. (B).<br />
1967; 28:2203B. (NA38)<br />
483. Powell GW, Miller WJ, Blackmon DM. Effects of dietary <strong>EDTA</strong> and cadmium on absorption,<br />
excretion and retention of orally administered 65Zn in various tissues of zinc-deficient and normal goats<br />
and calves. J Nutr. 1967; 93:203-212. (NA38)<br />
484. Princiotto JV, Zapolski EJ, Bagley Jr. DH, Laskey A, Morgan R, Rubin M. Absorption of oral<br />
chelated iron. Biochem. Med. 1970 3:289-297.<br />
485. Radnai I, Szabo V, Varhegyi J. Effectiveness of various manganese preparations (for cattle feeds).<br />
Magy. Allatory. Lapja. 1969; 24(9):501-502. (CA72)<br />
486. Rieders F. Current concepts in the therapy of lead poisoning. In: Metal-Binding in Medicine; Seven<br />
MJ and Johnson LA, ed., Lippincott, Phila. 1960; pp. 143-145. (2185)<br />
487. Rieders F. Effect of oral Na2Ca ethylenediamine tetraacetate on urinary and fecal excretion of lead in<br />
rabbits. Fed. Proc. 13. 1954; Abstract No. 1303. (601)<br />
488. Rieders F. Effects of oral Na2Ca ethylenediamine tetraacetate (<strong>EDTA</strong>) on distribution of Fe, Cu, Zn,<br />
and Pb in rats. J Pharmacol. Exper. Therapy. 1955; 113:45. (643)<br />
489. Rieders F, Brieger H. Edathamil disodium calcium (Na2Ca<strong>EDTA</strong>): Absorption by the oral route -<br />
interactions with metals in vivo - diagnostic and therapeutic use. Proc. 7th Annual Mtg. Amer. Acad.<br />
Occup. Med. 1955; pp. 83-84. (1607)<br />
490. Rubin MI, Martell AE, Bersworth FC. The biological actions of the versenes. Versenes, Inc.,<br />
Framingham, Mass. 1954, 84 pp.<br />
491. Rubin M, Princiotto JV. Synthetic amino acid chelating agents and iron metabolism. Ann. NY Acad.<br />
Sci. 1960; 88:450-459. (CA55:2903f)<br />
492. Sanchez Sanchez ML, Arroyo Vicente M, Elias Arcalis A, Rubio Perez P. Comparative study of oral<br />
and intravenous tests using calcium-<strong>EDTA</strong> to measure lead deposits in the body. Rev. Clin. Esp. 1983;<br />
169:241-244.<br />
493. Ruiz R, Van Soest PJ, Van Amburgh ME, Fox DG, Robertson JB. Use of chromium mordanted<br />
neutral detergent residue as a predictor of fecal output to estimate intake in grazing high producing Holstein<br />
cows. Anim. Feed Sci. Technol. 2001; 89(3-4):155-164. (CA)<br />
494. Sassi C, Finuli M, Nava C. Lead intoxication in workers exposed to lead stearate. Med. Lavoro. 1961;<br />
52:658-667. (2329)<br />
495. Savicevic M, Ptrovic L, Stankovic M, Poleti D. Prophylactic oral administration of Mosatil in lead<br />
exposed workers. II. Administration of 1- and 3-g, Mosatil tablets per day. Zentralblatt Arbeitsmedizin<br />
Arbeitsschutz. 1959; 9:289-292. (2064)<br />
496. Sawamura R, Fernandes MIM, Troncon LE de A. Alteracoe da permeabilidade intestinal em criancas.<br />
Arq. Gastroenterol. 1994; 31:30-38.<br />
497. Sawamura R, Fernandes MIM, Troncon LE de A, Iazigi N. Aumento da permeabilidade intestinal ao<br />
51Cr-<strong>EDTA</strong> em criancas com diarreia persistente. Arq. Gastroenteroo. 1997; 34:55-59.
498. Schardein JL, Sakowski R, Petrere J, Humphrey RR. Teratogenesis studies with <strong>EDTA</strong> and its salts in<br />
rats. Toxicol. App. Pharmacol. 1981; 61:423-428.<br />
499. Savicevic M, Petrovic L, Stankovic M, Djordjevic S. Prophylactic oral administration of Ca2<strong>EDTA</strong><br />
(Mosatil-Bayer) to workers exposed to lead. I. Administration of 2 g Ca2<strong>EDTA</strong> per day. Zentralblatt<br />
Arbeitsmedizin Arbeitsschutz. 1959; 9:180-185. (2063)<br />
<strong>500</strong>. Schmidt P. Nutritional and hematological disturbances in rats after gastrectomy in rats. Kiserl.<br />
Orvostud. 1974; 26(6):655-664. (CA82)<br />
501. Schroeder HA, moderator. Discussion. In: Metal-Binding in Medicine by MJ Seven and LA Johnson,<br />
Ed., JB Lippincott Co., Phila. 1960; p. 154-159.<br />
502. Schroeder HA. A practical method for the reduction of plasma cholesterol in man. Chron. Dis. 1956;<br />
4:461-468.<br />
503. Seeberg VP, Hidalgo J, Wilken W. Hemoglobin regeneration following oral administration of chelated<br />
iron. Science. 1954; 119-608-609.<br />
504. Shibata S. Toxicological studies of <strong>EDTA</strong> salt (disodium ethylenediaminetetraacetate). Nippon<br />
Yakurigaku Zasshi. 1956; 52:113-119. (CA51:9918b)<br />
505. Shaw JH, Gupta OP. The relation of a chelating agent to smooth-surface lesions in the white rat. J<br />
Nutr. 1956; 60:311-322. (CA51:12323a) [The results suggest that the smooth surface lesions observed were<br />
more likely to be closely related or identical to smooth surface caries than to be the result of the simple<br />
process of decalcification of tooth substance by chelation with ethylenediaminetetraacetic acid.]<br />
506. Shapiro R. Chelates in contrast roentgenography. In: Metal-Binding in Medicine, by MJ Seven and<br />
LA Johnson, Ed., JB Lippincott Co., Phila. 1960; p. 249-254.<br />
507. Semenov AI, Moskalev YI. Effect of age and chelating agents on the absorption of curium-244 from<br />
the gastrointestinal tract. Radiobiologiya. 1975; 15(5):780-783. (CA)<br />
Gordon Research Institute / Reference Material